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MECHANISMS OF COMPLEMENT RESISTANCE
NAEGLERIA FOWLERI AMOEBAE.

BY

PATHOGENIC

ABSTRACT

A dissertation submitted in partial fulfillment of the requirements for the Degree
of Doctor of Philosophy at Virginia Commonwealth University.
Denise Marie Toney
Virginia Commonwealth University
Maj or Director: Dr. Francine Marciano-Cabral

The genus Naegleria is composed of a distinct group of free-living
amoeboflagellates that include both pathogenic and nonpathogenic species.

N.

Jowleri, the only pathogenic species of Naegleria to be isolated from humans, is the

etiological agent of primary amoebic meningoencephalitis, a rare but rapidly fatal
disease of the central neIVOUS system in humans and in laboratory animals. The
mechanisms of pathogenicity and the determinants of virulence of N. Jowleri are
unknown. Both pathogenic and nonpathogenic Naegleria activate the alternative
complement pathway, however pathogenicN. Jowleri are complement-resistant and
nonpathogenic N. gruberi are complement-sensitive.

The ability to resist

complement-mediated lysis may be an important determinant of virulence of N.
Jowleri. These studies demonstrate that pathogenic N. Jowleri possess at least two

xii

mechanisms for resisting complement lysis. Pathogenic N. Jowleri synthesize a
surface associated protein which appears to possess structural as well as functional
homology to the human complement regulatory glycoprotein, CD59. Also, other
surface glycoproteins appear to play a role in regulating complement lysis either
directly or by indirect inhibitory mechanisms.

In

addition to complement

regulatory glycoproteins, pathogenic N. Jowleri possess the ability to remove
membrane deposited complement proteins, C5b-C9, from their cell surface by
membrane vesiculation. The presence of complement regulatory proteins and the
ability to vesiculate in response to serum complement, alone or in combination,
serves to protect pathogenic N. Jowleri from complement-mediated damage.
Nonpathogenic N. gntberi do not appear to possess surface complement regulatory
proteins or the ability to vesiculate in response to serum complement. Additional
studies demonstrate that growth medium modulates complement resistance and
virulence. More importantly, by using changes in growth medium, an in vitro
model was developed for differentially expressing proteins associated with the
complement-resistant state. The induction of these de n ovo synthesized proteins
may serve as markers of virulence and complement resistance in pathogenic N.
Jowleri amoebae.

Introduction

Primary amoebic meningoencephalitis

The genus Naeglena is composed of a distinct group of free-living
amoeboflagellates that include both pathogenic and nonpathogenic species.
Naeglena species can be isolated from a variety of environmental sources including

soil and freshwater habitats [6 1]. N. Jowlen, the only pathogenic species of
Naeglena to be isolated from humans, is the etiological agent of primary amoebic

meningoencephalitis (PAME). PAME is a rare but rapidly fatal disease of the
central nervous system in humans and in laboratory animals ( 12, 13, 17] .
Outbreaks of PAME have been reported from Australia, Czechoslovakia, and the
United States [1]. PAME occurs in healthy children and young adults with a
recent history of swimming in freshwater lakes and ponds. Infection is initiated by
the introduction of water containing amoebic trophozoites into the nasal cavity of
the host. The amoebae gain entry into the brain by penetrating the nasal mucosa
and the olfactory apparatus. Once in the brain, the amoebae cause extensive
tissue damage and inflammation. Death occurs in approximately 10- 14 days [ 13,
43, 66]. The pathogenesis of PAME is poorly understood. Haematogenous spread
of N. Jowlen has not been observed in human cases and is believed to be due to
1

2
amoebicidal factors in serum [13]. Mice or guinea pigs infected intranasally
develop a fatal disease resembling PAME in humans. The mouse model has been
used extensively to study host resistance to infection by N. fowleri [65, 100].

Growth and cultivation

In the environment, N. fowleri amoebae feed on bacteria and yeast. In the
laboratory, environmental Naegleria isolates can be adapted to growth on non
nutrient agar containing Escherichia coli or Enterobacter aerogenes [44]. However,
axenic culture of Naegleria is necessary for biochemical and molecular studies of
the amoebae.

A

number of complex liquid media have been developed for axenic

cultivation of the amoebae [31, 61]. Pathogenic N. fowleri can be cultured
axenically in Nelson medium consisting of liver digest, glucose and serum in Page
amoeba saline [81, 124]. Nonpathogenic N. gruberi cannot be easily cultivated in
Nelson medium. Instead, Balamuth (H4) medium is used for the cultivation of
N. gruberi amoebae. Balamuth (H4) medium consists of liver digest, glucose,
serum, protease peptone, yeast extract and bovine hemin in Page amoeba saline

[4]. To allow for comparisons, b oth pathogenic N. fowleri and nonpathogenic N.
gruberi can be cultivated in Cline medium which consists of a mixture of H4

medium and Nelson medium [14].
Prolonged growth of pathogenic N. fowleri amoebae in axenic culture
results in attenuation of virulence. Serial passage of N. fowleri through mice
maintains the virulence of the amoebae [125, 129]. Studies have demonstrated
that

growth medium influences both biochemical and physiological functions of

3

Naegleria amoebae.

Factors such as growth rate, virulence, susceptibility to

complement, rate of locomotion, temperature tolerance, drug susceptibility, and
protein profiles were shown to differ depending on the growth medium in which
amoebae were maintained [14, 40, 63, 120].

Humoral and cell-mediated immunity

The mechanisms responsible for pathogenicity of N. fowleri are unknown.
[100].

Mice immunized by repeated administration of formalinized amoebae,

freeze-thawed amoebic extracts, or sublethal doses of live amoebae develop
species-specific agglutinating antibodies [29, 100, 117].

Although a marked

humoral response has been observed in immunized mice, all immunization
regimens have produced only modest protection against infection by N. fowleri.
Failure to impair host resistance with immunosuppressive treatments such as
cyclophosphamide or 6O Co-irradiation indicates that humoral immunity is not a
major line of host defense against PAME.

Newsome and Arnold [83]

demonstrated that congenitally athymic mice (T cell-deficient) and euthymic mice
were equally susceptibile to infection by N. fowleri. In addition to these studies,
an inability to impair host resistance to N. fowleri infection with diethylstilbestrol,
which depresses delayed-type hypersensitivity, corroborates the suggestion that .
cell-mediated immunity alone, is not involved in host resistance against N. fowleri
infections [100].

4
Innate resistance

Innate resistance factors appear to play a more important role than·
acquired immunity for host defense against N. Jowleri infection [ 1 00].
Susceptibility to N. Jowleri varies greatly among mouse strains.

The most

susceptible mouse model of PAME is the C5 complement-deficient strain A/HeCr
[28]. Experimental evidence suggests that complement is an important factor in
host defense against N. Jowleri since complement-deficient mice or cobra venom
factor-treated mice are more susceptible to infection by N. Jowleri [28, 1 00] . The
pathogenicity of Naegleria amoebae in vivo correlates with resistance to
complement-mediated lysis in vitro. Both pathogenic and nonpathogenic Naegleria
amoebae

activate

the

alternative

complement

pathway

however,

only

nonpathogenic amoebae are readily lysed by human complement [39, 125]. The
ability of highly-pathogenic N. Jowleri to activate complement and convert
complement component C5 to C5b suggests that the point of complement
regulation must occur at the terminal stage of the complement cascade, membrane
attack complex (MAC) formation [ 126] . The Naeglerial components that activate
the complement cascade but allow highly-pathogenic
complement-mediated damage are unknown.

N.

fowleri to escape

Enzymatic removal of surface

components from amoebae with trypsin or papain, but not sialidase increase the
susceptibility of complement-resistant amoebae to complement lysis, indicating
that proteins on the surface of the amoebae play a role in resistance to
complement lysis [ 126] .

However, the inability of protease inhibitors to block

complement resistance in vitro suggests that a complement-specific protease is not

5
involved in resistance of N. Jowleri to complement lysis [ 126].

The ability of

highly-pathogenic N. Jowleri to escape complement lysis may be an important
virulence factor in the pathogenesis of PAME.

The complement system

The complement system consists of a series of more than 30 soluble and
membrane bound plasma proteins which interact in a sequential cascade to cause
irreversible damage to the membranes of cellular targets. [5, 67, 80]. The
complement cascade can be initiated by both immunological and non
immunological stimuli and depends on the conversion of serum zymogens to active
serine esterases.

When activated, the complement proteins together have the

ability to destroy microorganisms including bacteria, viruses, parasites, and tumor
cells. Complement proteins, also, play a role in eliminating foreign antigens from
tissues and blood [53] . In addition to its involvement in anti-microbial immunity,
the complement system is involved in inflammatory tissue damage seen in a
variety of diseases [104].
The complement system can be initiated by two distinct pathways, the
classical pathway which is antibody-dependent and the alternative pathway which
is antibody-independent (Fig 1).

The presence of two different pathways for

complement activation allows for augmented host immunity and serves as a bridge
between the cellular and humoral immune systems. The role of these activation
pathways is to produce enzymes which activate complement component C3. The
classical pathway (C1 through C9) is activated by the binding of complement
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component C1 to immune complexes by virtue of the affinity of the globular heads
of C1q for the Fc portion of antigen-bound immunoglobulin, specifically IgM,
IgG 1, IgG2, or IgG3. Once bound to antibody, C1 is capable of proteolytically
cleaving complement components

C4

and C2 resulting in the formation of a

C4b2a complex termed the C3 convertase, on the cell surface of microorganisms
[53]. Activation of the classical complement pathway requires development of
humoral immunity (antibody) against a target cell or antigen.
The alternative complement pathway (ACP) occurs in the absence of
antibody. Instead, the ACP is activated by microbial cell wall constituents such
as particulate polysaccharides and lipopolysaccharides, or by the spontaneous
hydrolysis of the intramolecular thioester bond of complement component C3 in
the fluid phase. Hydrolysis of C3 results in a product which possesses a C3b-like
conformation, termed C3(H20). The hydrolyzed C3(H20) then interacts with
Factors B and D resulting in formation of an alternative pathway C3 convertase,
C3(H20)Bb [25, 53, 74, 79, 80] .
Although each pathway is initiated by different mechanisms, the C3
convertases formed by either pathway are homologous and serve to split multiple
C3 molecules. The association of C3b with the C3 convertase of either pathway
results in the formation of an enzyme that activates and cleaves complement
component C5. The products resulting from cleavage of component C5 are C5a
and C5b [53]. The generation of C5b serves as the first step in MAC formation.
The C5b fragment possesses a labile binding site for C6. The C5b6 complex
remains loosely associated with the cell membrane until component C7 binds.
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Figure 1: Schematic diagram of the complement cascade. Asterisks denote sites
controlled by complement regulatory proteins or regulatory mechanisms.
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The binding of C7 to C5b6 causes a conformational change whereby hydrophobic
sites are exposed, resulting in the anchoring of the complex to the lipid bilayer [32,
80]. Membrane deposited C5b67 reacts with C8 and C9 to form a multimolecular
complex termed the MAC which creates pores within cell membranes [88]. The
final events of MAC assembly are unfolding and polymerization of complement
component C9 within the target membrane, which causes weakening of membrane
structure, formation of transmembrane channels, and subsequent cell lysis. The
importance of the terminal complement proteins comprising the MAC (C5, C6,
C7, C8, or C9) is best demonstrated by the fact that individuals with inherited
deficiencies in the production of these proteins suffer from gram negative bacterial
infections such as Neisseria m eningitidis or Neisseria gono"hoeae [92,

103].

Complement pathway regulation

Complement activation on cell membranes is controlled by both fluid-phase
and membrane-bound regulators [74].

These regulators act to control normal

complement activation to prevent complement depletion, and to prevent lysis of
homologous or "self' blood cells [2]. The inability of individuals to properly
regulate the complement pathway results in a number of acquired and inherited
disorders

including

hemoglobinuria

[20,

hereditary
37] .

angioedema

and

paroximal

nocturnal·

However, most individuals are not predisposed to

diseases of this type due to the ability to synthesize complement regulatory
proteins.

Eukaryotic cells including neutrophils and erythrocytes possess

complement regulatory proteins which protect them from homologous complement
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damage.

Regulatory proteins include decay accelerating factor (DAF),

homologous restriction factor (HRF), and CD59, all of which possess glycosyl
phosphatidylinositol (GPI) membrane anchors [70, 88, 130]. DAF is a membrane
bound glycoprotein (MW 65-70 kDa) present on virtually all peripheral blood,
epithelial and endothelial cells which inhibits the amplification enzymes, C3 and
C5 convertases of the complement cascade [35, 36, 52, 85]. Inhibition by DAF
prevents continuation of the complement cascade and subsequent target cell lysis
[2 1, 59, 68, 69, 70, 84] . HRF (MW 65-70 kDa) and CD59 (MW 18-20 kDa) are
inhibitory glycoproteins which interfere with the assembly of the terminal
complement proteins comprising the MAC (C5b-C9). Both HRF and CD59 exert
their inhibitory action by interferring with the binding of components C8 and C9
to the forming MAC [38, 87, 109, 1 1 1, 130]. Specifically, CD59 has been shown
to bind to the a-chain of C8 and the "b" domain of C9 thereby preventing the
interaction of the two proteins with each other. The ability of CD59 to bind to
either the C5b-8 or C5b-9 complex serves to limit poly-C9 polymerization within
cell membranes and restrict pore formation and subsequent cell lysis [86] . CD59
has been given numerous names by different investigators, including membrane
inhibitor of reactive lysis, H19, 1FSag, Pl8'-20, and protectin [ 18, 37, 38, 7 1, 88, 89,
102, 1 13, 1 14, 127] .
Complement regulatory molecules have been found on many different cell
types but their individual distribution varies with their particular function. In
addition to the presence of complement regulatory proteins, pathogenic bacteria,
protozoa, tumor cells, erythrocytes and platelets utilize additional mechanisms to

11

protect their membranes following complement attack in order to prevent
complement-mediated lysis [51, 75, 76, 77]. Mechanisms of complement evasion
can occur at numerous sites along the complement cascade [46]. Evasion may
occur because the complement pathway is not properly activated or because the
pathway is blocked prior to formation of the MAC [54]. Neutrophils, erythrocytes,
platelets and some protozoa evade complement lysis by the physical removal of
membrane attack complexes from their cell surface in the form of membrane
vesicles, a mechanism termed vesiculation [26, 75, 76, 77]. In addition, cells may
rapidly degrade or inactivate the complement components once deposited on the
membrane surface [50, 75, 77].

Complement and parasites

The interaction of complement with parasitic organisms such as protozoa
and

helminths has been described [108].

Both the classical and alternative

complement pathways are activated in vivo and in vitro by parasitic organisms.
However, a number of parasites escape complement-mediated lysis by either
synthesizing complement regulatory proteins, acquiring host complement
regulatory proteins or by inactivating specific components of the complement
pathway.

E.

histolytica is an intestinal amoeba which activates the ACP, however

only virulent strains resist complement-mediated damage [41, 72, 73, 97, 98].
Passage of amoebae through mice or hamsters maintains pathogenicity and
complement-resistance. Growth of pathogenic amoebae in the presence of active
complement also maintains complement resistance in vitro.

A correlation
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between complement resistance and pathogenicity of E. histolytica has been
demonstrated [72]. Complement has been shown to be involved in host defense
to infection by E.histolytica since complement depletion using cobra venom factor
enhances liver abscess formation in hamsters [11]. Reed et aL [97] demonstrated
that pathogenic strains of E. histolytica deplete or bind complement proteins more
rapidly as compared to nonpathogenic strains of amoebae.

However, the

mechanism by which pathogenic E. histolytica resists complement lysis is not
clearly defined. Antisera to the galactose-specific adherence lectin, a major surface
glycoprotein of

E.

histolytica was shown to increase the susceptibility of

complement-resistant E. histolytica suggesting that this surface protein may be
involved in regulating complement [8]. Others have suggested that restriction of
additional C9 binding may be involved in conferring resistance to complement in
vitro [8, 99]. A similar mechanism has been attributed to HRF and CD59.

Sequence similarities between the adherence lectin and CD59 corroborates the
hypothesis that these two proteins possess similar complement regulatory abilities
[8]. In addition to the presence of complement-inhibitory proteins, it has been

hypothesized that complement-resistant strains of E. histolytica are capable of
endocytosing the MAC in order to prevent complement-mediated lysis [26 ].
Bloodstream forms of the parasite, Trypan osom a cruzi, are resistant to lysis
by complement [9, 42, 47,50,54,55]. Enzymatic treatment studies suggests that
trypanosomal surface proteins may be involved in the mechanism of complement
regulation of T. cruzi. Trypomastigotes of T. cruzi (strains M88 and Y) synthesize
an

87-93 kDa glycoprotein which possesses 40-50% sequence homology and have
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functional homology to the complement-regulatory molecule, DAF [ 16, 30, 47, 5 0,
55, 101]. Amastigotes of T. cruzi are protected from complement-mediated lysis
due to an inability of the terminal complement proteins, C5b-9 to insert in the
plasma membrane of the parasite,

a

mechanism analogous to HRF or CD59 of

mammalian cells.
The promastigote stage of Leishm ania spp. activates complement resulting
in the deposition of C3b on the surface of the parasite.

The major surface

glycoprotein of L.m ajor is a promastigote surface protease (GP63) which cleaves
complement component C3b into an inactive form, C3bi. This inactive form
enables L. m ajor to evade complement lysis by inhibiting further complement
activation [6, 15]. The C3bi fragment also acts as a ligand for the binding to
complement receptors on macrophages, allowing L.m ajor promastigotes to enter
into host cell macrophages and further evade the host' s immune system [6, 78] . In
addition to the presence of GP63, L.m ajor possesses a second major cell surface
protein termed lipophosphoglycan (LPG) which has been proposed to interfere
with the stable insertion of the MAC (C5b-9) within its cell membrane [95]. Both
the promastigote surface protease and LPG are attached

to the surface of

L.

m ajor by a GPI-anchor [6, 121].

Complement activation and deposition on larval schistosomes has been
reported [ 122] .

Cercariae and early skin-stage schistosomula of Schistosom a

m ansoni possess a high molecular weight glycocalyx consisting of carbohydrates

and proteins which is highly antigenic and a strong activator of the ACP [23, 107,
1 08, 122]. Schistosomula become progressively resistant to ACP-mediated damage
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by the rapid shedding of the surface glycocalyx which serves as a umque
mechanism for diverting the immune system [23, 105, 106] .

In addition,

schistosomula incubated in serum-free media shed substances which normally
consume C3 from serum [64]. This C3 consumption converts the schistosomula
into a non-activator of the ACP, and renders the schistosomula complement
resistant [64, 96]. Recently, proteins have been identified on the surface of S.
m ansoni which regulate complement-mediated lysis. A protein of approximate

molecular mass 70 kDa is proposed to possess C3b-binding activity, however the
mechanism is not clearly defined. A second inhibitor prevents MAC formation,
suggesting that the protein is CD59-like [as cited 24]. In addition, S.m ansoni also,
have the capacity to acquire regulatory proteins from host tissues such as DAF,
which then serve to protect the parasite from complement damage [9 1 ] .
Thus, pathogenic protozoa and helminths have evolved diverse mechanisms
for escaping complement-mediated lysis and evading the immune system. The
Naeglerial components which activate complement and modulate the lytic process
to allow highly-pathogenic Naegleria Jowleri to escape the amoebicidal activity of
serum are unknown. These studies will allow for the identification of specific
mechanisms which allow highly-pathogenic N. Jowleri amoebae to escape
complement-mediated lysis as well as extend our knowledge of the survival
strategies utilized by pathogenic organisms such as N. Jowleri, to escape the host' s
immune system. The information will provide an understanding of the role of the
complement system in parasitic infections, and increase our knowledge of the
mechanisms employed by many pathogens and tumor cells to evade host immunity.
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More importantly, studies to evaluate the biochemical basis for the transformation
of free-living organisms such as N. fowlen into highly-virulent human pathogens
should provide useful insight for establishing successful treatments for this and
other fatal diseases.

Study objectives

The first objective was to investigate the ability of growth medium to
modulate biochemical and physiological functions of N. fowlen amoebae.
Specifically, my objective was to evaluate the effect of growth medium on the
susceptibility of complement-resistant N. fowlen to complement lysis and on
virulence of the amoebae for mice. Growth medium has been demonstrated to
effect a number of physiological and biochemical factors in N. fowlen amoebae
such as temperature tolerance, enflagellation, rate of locomotion, food-cup
formation and susceptibility to drug treatment [ 14, 63] .
Th e second objective of this study was to examine and compare surface
proteins of highly-pathogenic, weakly-pathogenic and nonpathogenic Naeglena in
order to identify specific proteins which may play a role in resistance of
pathogenic amoebae to complement-mediated lysis.

Previous studies have

demonstrated that treatment of highly-pathogenic, complement-resistant N. fowlen
with papain or trypsin, to remove surface proteins increased the susceptibility of
highly-pathogenic amoebae to complement lysis. Enzymatic treatment of weakly
pathogenic or nonpathogenic amoebae had no effect on complement lysis [ 126].
The third objective of this study was to determine whether pathogenic

N.

.

16
Jowleri use additional biochemical or cellular mechanisms, such

as

membrane

vesiculation, for resisting complement-mediated damage. It is well established that
a number of pathogenic bacteria and nucleated cells resist complement damage
by the physical removal of complement proteins, specifically the MAC from their
cell surface via exocytic processes, a process termed membrane vesiculation [77,
76] .

Materials and Methods

Amoebae

N. Jowleri LEE (ATCC 30894) was isolated in 1968 at the Medical College
of Virginia Hospital in Richmond, Virginia, from the brain of a patient with
primary amoebic meningoencephalitis [8 1].

This strain has been cultured

axenically in the laboratory since its isolation and is weakly-pathogenic in mice.
N. Jowleri LEEmpCl, a highly-pathogenic strain in experimental animals,
was derived from the LEE strain by passaging the amoebae through B 6C3F 1 mice
at monthly intervals. Mice were infected intranasally with amoebae. Mter 4 days,
amoebae obtained from samples of brain from infected mice were cultured
axenically in Nelson medium or Cline medium at 37 ° C for a period of not more
than 1 month.

After 1 month of in vitro axenic culture, the amoebae were

passaged again through mice.

After 75 consecutive mouse-passages at monthly

intervals, the amoebae were cloned by serial dilution in micro titer well plates to
obtain one amoeba per well.

Wells containing one amoeba were grown to

confluency and serial dilutions of the cultures were continued for 20 growth cycles.
A highly-pathogenic strain ofN. Jowleri, LEEmpCl (LEE mouse-passage Clone 1)
which consisted of a homogeneous population was used for these studies. The
17
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strain used in these studies has been passaged through mice a minimum of 100
times.
N. gmberi (EGB), a nonpathogenic, complement-sensitive soil isolate, was
grown in Cline medium at 30 ° C [ 1 10, 125]. Cultures of amoebae were grown
axenically in 75 cm2 plastic tissue culture flasks (Nunc Inc., Naperville, IL) in
either Nelson medium or in Cline medium which consisted of equal parts of
Nelson medium and Balamuth medium [3, 4, 14, 61].

Amoeba growth medium

Nelson medium consisted of 0. 1 % (wIv) liver digest (Panmede; Paines and
Byrne Limited, Greenford, England), 0. 1 % D-( + )-glucose (Sigma Chemical Co.,
St. Louis, MO) and 2.0% calf serum (BioWhittaker, Walkersville, MD) in Page
amoeba saline [6 1] comprised of 2 mM NaCI, 0.016 mM MgS04 7H20, 1 mM
NazHP04' 0.027 mM CaCl2 2H20, 1 mM KH2P04 .
Cline medium [ 14] consisted of 0.55 % (w/v) liver digest, 0.3% (w/v)
glucose, 0.5 % (wIv) Bacto-Peptone (Difco Laboratories, Detroit, MI), 0.25 % yeast
extract (Difco), 1.0% calf serum and 0. 1% (w/v) bovine hemin (Sigma) in Page
amoeba saline.

Complement reagents

Normal guinea pig complement (NGPC) or normal human serum (NHS)
which served as the complement source were purchased from Sigma or Gibco
Laboratories (Grand Island, NY), dispensed into vials and stored at _70 ° C.
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Purified complement component, C9, and C9-deficient NHS were purchased from
Sigma or Quidel (San Diego, CA). Polyclonal rabbit antiserum to the human
complement proteins comprising the membrane attack complex (anti-MAC) was
purchased from CalBiochem (LaJolla, CA).

Monospecific polyclonal rabbit

antiserum to human erythrocyte CD59 was a provided by Dr. Peter Sims at the
Wisconsin Blood Center (Milwaukee, WI).

Amoeba growth rate

Erlenmeyer flasks containing 50 ml of either Nelson medium or Cline
medium were inoculated under sterile conditions with 1 x 1<r amoebae per ml and
allowed to grow at 37 ° C with gentle agitation in a shaker incubator for 5 d. At
approximately 24 h intervals, aliquots of the mixture were removed, and the
number of amoebae were quantitated using a hemacytometer. Counts represent
the mean number of amoebae determined from 5 separate flasks with a minimum
of 5 counts per flask.

Amoebicidal assay

Log-phase cultures of Naegleria amoebae were labeled for 24 h with 50J..l. Ci
of [3H]uridine (New England Nuclear/Dupont, Boston MA) at 37 ° C for both
strains of N. fowleri or at 30 ° C for N. gmberi. Amoebae were harvested by
centrifugation, washed three times in Hank's balanced salt solution (HBSS) to
remove unincorporated [3H]uridine label and suspended in either gelatin veronal
buffer (GVB+ +) or HBSS. Amoebae were counted using a hemacytometer and
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adjusted to a cell density of 1 x 106 amoebae per ml. NGPC or NHS was diluted
in either GVB + + or HBSS, placed into 96-well microtiter plates (Nunc) and mixed
with (1 x lOS) [3H]uridine-Iabeled amoebae for 1 h at 37 ° C. Following incubation,
the supernatant fluid and pellet were harvested separately and the counts per
minute (CPM) in each determined. The percent specific release of radiolabel
from the amoebae was determined using the following formula:
CPM
% Specific Release

=

experimental

-

CPM

spontaneous

------

CPM

maximum release

- CPM

x 100

spontaneous

The percent specific release of radiolabel was used as an index of cell lysis [ 125] .
All data were analyzed statistically using the two-tailed Student' s t test.

Determination of alternative pathway-complement hemolytic (AP-CHso) units

The percent of complement hemolytic units depleted from NHS following
incubation with N. Jowlen LEEmpC1 was measured by ACP activation [94] . NHS
or buffer was

diluted with

10 mM Mg-EGTA

and incubated with N.

Jowleri

amoebae (1 x lOS) or buffer. Following incubation, cell-free serum or buffer was
added

to a series of test tubes containing 1 x 107 rabbit erythrocytes suspended in

Mg-EGTA, and incubated for 60 min at 37 ° C with gentle agitation. Following
incubation, 2 ml of isotonic saline were added to all the tubes to stop the reaction.
Tubes were centrifuged to pellet remaining intact erythrocytes and the optical
density (OD) of the supernatant fluid was determined at 4 14

nm.

Parallel tubes
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containing Mg-EGTA buffer and rabbit erythrocytes were incubated for 60 min
at 37 ° C and 2 ml of distilled water were added to the mixture to produce 1 00%
lysis to serve as a positive control. The proportion of cells which were lysed (y)
in each tube was calculated using the following formula:
OD4 14 sample tube
y

=

-

OD4 14 cell blank

-------

OD4 14 100% lysis tube

-

OD4 14 cell blank

The value of K, a constant representing the 50% unit of complement (x intercept)
was obtained by plotting log (x) against log [Y/(l-y)], where x is the volume (JLl)
of serum added to each tube. The number of AP-CHso units/ml equals the initial
dilution of the serum used multiplied by a factor of 1000. Values are expressed
as the percentage of complement hemolytic units depleted as compared to the
initial complement hemolytic activity of the serum prior to incubation with

N.

Jowlen amoebae.

Effect of supplemental hemin on susceptibility of N. fowleri to complement lysis

Log-phase cultures ofN. Jowlen LEEmpC1 amoebae were grown in Nelson
or Cline medium supplemented with bovine hemin (0. 1%) for a minimum of 20 .
°
days. Amoebae were labeled for 24 h with 50JLCi of [3H]uridine at 37 C and

susceptibility to complement lysis was determined using the amoebicidal assay
described above.
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Media shift of N. fowleri in the absence or presence of cycloheximide

Log-phase cultures ofN. Jowleri LEEmpCI grown in either Nelson or Cline
medium for a minimum of 20 days were labeled for 24 hr at 37 °C with 50 J,£Ci of
[3H]uridine. Nelson medium was removed from the flasks containing [ 3H]uridine
labeled amoebae and replaced with Cline medium. The amoebae were allowed
to incubate for an additional 2 to 4 h. Amoebae maintained in Nelson medium
or Cline medium served as controls. Parallel cultures of 3 [H]uridine-Iabeled
amoebae grown in Nelson medium were pretreated with 5J,£g/ml of cycloheximide
for 4 h followed by a 2 h shift to growth in Cline medium containing
cycloheximide. Following incubation, amoebae were harvested and incubated in
NGPC for I h at 37 ° C. The percent specific release of radiolabel was determined
by the amoebicidal assay.

Autoradiographic analysis of metabolically-labeled N. fowleri subjected to medium
shift

To identify polypeptides synthesized during media shifts,

N.

Jowleri

LEEmpCI maintained in axenic culture for a minimum of 20 days, were grown to
confluency in 25-cm2 plastic tissue culture flasks in either Nelson or Cline medium
at 37 ° C. Amoebae maintained in Nelson medium were shifted to growth in Cline
medium containing Tran35 [S]methionine:cysteine radiolabel (ICN Biomedicals,
Inc., Irvine, CA) for 2 h at 37 ° C. Following radiolabeling, the amoebae were
harvested by centrifugation, washed in HBSS and subjected to lysis with a lysis
buffer cocktail consisting of 2 mM Tris, 100 mM NaCI, 2% (v/v) Triton X- IOO,
0.5 % (w/v) sodium deoxycholate and 4 mM NaN3 containing the protease
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inhibitors: 0.2 U/ml aprotinin, 0. 1 mM phenylmethylsulfphonyl fluoride (PMSF)
and 5 mM iodoacetamide (Sigma). The protein concentration of the lysates was
determined using a modified Bradford's protein microassay [7] . Radiolabeled
proteins (50 I-'g) were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) [56], the gels dried on Whatman paper (BioRad)
under vacuum and heat and exposed at _70 ° C to RP X-Omat XRP-5 diagnostic
film (Eastman Kodak Co., Rochester, NY) for 14 d.

Image analysis

Autoradiographic films were analyzed in a Shimadzu CS9000U Dual
Wavelength Flying-spot Scanner (Shimadzu Corp., Kyoto, Japan) interfaced to a
WIN 286 computer (Win Laboratories Ltd., Fairfax, VA) employing Quantascan
2D Analysis binary format and ASCII Conversion software (Shimadzu Corp.).
ASCII-converted files were analyzed further on a VAXcluster Computer System
(Digital

Equipment

Corp.,

Richmond,

VA)

using

Statistical

Analysis

System/Graph (SAS/GRAPH) software (SAS Institute, Inc., Cary NC).
SAS/GRAPH-analyzed data were subjected to final analysis using a WIN 386
Computer (Win Laboratories) utilizing QGEL Analysis Software (HBI,
Saddlebrook, NJ). Band intensities were integrated and quantitated resulting in
a relative density volume value used for comparative analyses.

Virulence of N. fowleri for mice

Virulence studies were conducted using 8-week old female B 6C3F l mice.
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Mice were inoculated intranasally with

N.

Jowleri LEEmpC1 amoebae ( 1

x

Hf)

grown for approximately 10 or 30 d in either Nelson or Cline medium. The
number of deaths in each group was recorded daily for 30 d. On day 30, surviving
mice were sacrificed and autopsied to determine whether brain tissue contained
amoebae.

Enzymatic treatment of live NaeKleria trophozoites

Log-phase cultures of pathogenic and nonpathogenic Naegleria spp. were
radiolabeled with [ 3H]uridine for 24 h at 37°C or 30°C respectively. Trophozoites
were harvested by centrifugation, washed free of excess radiolabel and adjusted
to a cell density of 1 x 106 amoebae per ml. Aliquots (1 ml) of diluted amoebae
were placed in 1.5 ml polypropylene microfuge tubes (American Scientific,
Columbia,

MD)

and

treated

with

500mU

phosphatidylinositol-specific

phospholipase C (PIPLC) purified from Bacillus thu ringiensis (ICN Biochemicals,
Cleveland, OH) for 1 h at 37°C with gentle agitation.

Following enzymatic

treatment, PIPLC-treated amoebae were removed and washed free of PIPLC.
Radiolabeled PIPLC-treated or untreated amoebae were incubated with diluted

NGPC in 96-well microtiter plates and the percent specific release of radiolabel
was determined using the amoebicidal assay.
eH]uridine-labeled Naegleria spp. (1

x

lOS) were incubated with 40mU of

Endo-B-N-acetylglucosaminidase H (endo H) from Streptomyces lividans
(Boehringer-Mannheim Biochemicals, Indianapolis, IN) diluted in a mixture of
phosphate buffered saline (PBS) and HBSS pH 7.0 for 4 h at 37 ° C. Following
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incubation, the enzyme was removed and amoebae were washed twice with a
mixture of PBS and HBSS, suspended in GVB + + and incubated with diluted
NGPC for 1 h at 37 ° C. The percent specific release of radiolabel was determined
using the amoebicidal assay.

Tunicamycin treatment of Naea=leria amoebae

Log-phase cultures of pathogenic and nonpathogenic Naegleria amoebae
were grown in [3H]uridine-containing Cline medium in the absence or presence
of 2.0 or 3.0 J,£g/ml of tunicamycin (Sigma Chemical Co., St. Louis , MO) for 1 8
h at 37 ° C o r 30 ° C respectively. Following incubation, amoebae were harvested
by centrifugation and washed in HBSS to remove excess tunicamycin. Amoebae
were counted and 1 x lOS amoebae were incubated in diluted NGPC for 1 h at
37 ° C. Parallel cultures of amoebae were grown in Cline medium in the absence
or presence of tunicamycin for 18 h, followed by removal of the drug and
incubation in tunicamycin-free growth medium for 24 h. Amoebae were harvested
as described above and incubated in NGPC for 1 h at 37 ° C. The percent specific
release of radiolabel from the amoebae was determined using the amoebicidal

assay.

Determination of protein synthesis inhibition in Naea=leria amoebae

Naegleria amoebae were radiolabeled with 30J,£Ci/ml [35S]methionine (New

England Nuclear/DuPont) in Cline medium.

Labeling of cells with [35S]

methionine in the presence of tunicamycin was performed either immediately or
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after appropriate preincubation periods with the drug. After radiolabeling, the
amoebae were washed twice with cold HBSS and subjected to lysis using the lysis
buffer cocktail. Incorporation of [35S]methionine into newly synthesized proteins
was determined by precipitation using 5% (vIv) trichloroacetic acid (TCA) at 00 C.
The precipitates were collected onto 0.45J.'m nitrocellulose filters (Millipore Filter
Corp, Bedford, MA), washed with 10 ml of 5 % TCA containing 2mg/ml
methionine, dried and counted in 4 ml of Beckman Ready Protein scintillation
cocktail (Beckman Instruments Inc., Fullerton, CA). The protein concentration
of the pellets was determined and the specific activity (cpm/ J.'g protein) was
determined using the formula:
cpm/J.'l TCA precipitated protein
Specific Activity

=

J.'g protein/I.d of sample

Precipitates were analysed by SDS-PAGE and the polypeptide bands were
detected by staining with Coomassie Brilliant Blue R-250 (BioRad, Rockville
Centre, NY) at a final concentration of 0. 125%. Following staining, the gels were
dried on Whatman paper (BioRad) under vacuum and heat and then exposed at
_70 ° C to diagnostic film (Eastman Kodak Co.) for 14 days.

Surface Iodination of Nae&leria amoebae

Sterile glass vials were coated with 100J.'g of iodogen ( 1,3,4,6-tetrachloro3a,6a-diphenylglycouril) (Pierce Chemical Co., Rockford, IL), by dissolving
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iodogen in chloroform and drying under a stream of N2•

Vials were stored

dessicated at 4 ° C. Amoebae were washed in HBSS to remove residual growth
medium. Amoebae were harvested by centrifugation and incubated at room
temperature for 15 min in iodogen-coated vials in the presence or absence of 500
#loCi of Nal 251 with intermittent swirling. Following incubation, amoebae were
washed in cold HBSS containing 5 mM potassium iodide (KI) and subjected to
lysis using the lysis buffer cocktail as described previously. Incorporation of

1251

into protein was determined by precipitation using a mixture of 5 % TCA
containing 0.3 mg/ml

KI

and 150 mM NaCI containing 0.5 % fetal calf serum at

O ° C. Precipitates were pelleted by centrifugation and the CPM present in the
supernatant fluid and pellet were quantitated using a gamma counter.

The

concentration of protein in the pellets was determined as described above.
Samples of precipitated protein were analyzed by SDS-PAGE and Coomassie
Brilliant Blue staining. The gels were dried on Whatman paper under vacuum and
heat and exposed to film at room temperature for 28 h.

Trypan blue exclusion of iodinated Nae21eria amoebae

Viability of amoebae following surface iodination was assessed by mixing
equal volumes of amoebae with a 4% trypan blue (Sigma) solution following .
iodination in iodogen-coated vials. The amoebae were examined for exclusion of
dye using a hemacytometer and phase contrast microscopy. The ratio of live
versus dead amoebae was determined and the percent viability calculated.
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Biotinylated lectin analysis of NaeKleria amoebae

Lysates of amoebae subjected to surface iodination were used also, for
glycoprotein determination. Radiolabeled amoebic lysates (25J..Lg ) were separated
by SDS-PAGE and the proteins were transferred to nitrocellulose. Glycoproteins
were detected using VECfASTAIN ABC reagents (Vector Laboratories
Burlingame, CA).

Briefly, nitrocellulose membranes were incubated in Tris

buffered saline pH 7.5 containing 0. 1 % Tween-20 (Sigma) (TTBS) for 30

min.

Nitrocellulose membranes were incubated for 45 min with 20J..L g /ml of either
biotinylated Concanavalin A or biotinylated Ulex europ aeus agglutinin I suspended
in TTBS with gentle agitation. Following incubation, membranes were washed 3
times with TTBS and incubated for 30 min in horseradish peroxidase-conjugated
Avidin-D ( lOJ..L g/ml). Membranes were washed as before and developed using a
substrate solution containing diaminobenzidine-hydrochloric acid, H202 , and NiCI
(Sigma).

After development, the nitrocellulose blots were subjected to

autoradiography at _70 ° C for 4 days.

Anti-CDS9 immnnostaining of NaeKleria amoebae

Lysates from pathogenic and nonpathogenic Naeg/eria were generated using
the lysis buffer cocktail

as

described.

Erythrocyte ghosts were prepared by

washing fresh erythrocytes extensively in 5 mM phosphate buffer (KH2P04).
Hemoglobin-free erythrocyte ghosts were pelleted by centrifugation at 3000 xg for
10 min.

Pellets were subjected to a freeze-thaw cycle and the protein

concentration determined. Lysates from amoebae and erythrocyte membranes
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were subjected to 12% SDS-PAGE under non-reducing conditions and western
immunoblot analysis. Rainbow molecular weight markers (Amersham, Arlington
Heights, IL) were used to determine the relative molecular mass of the proteins.
Proteins were transferred to 0.45J,.£m nitrocellulose membranes (BioRad) in a
BioRad Transblot apparatus overnight at 90

rnA

(30 constant volts).

Nitrocellulose membranes were blocked with phosphate buffered saline (PBS)
containing 5% (wIv) nonfat dry milk, 5 mM (wIv) ethylenediamine tetraacetic
acid (EDTA), 0.01 % (v/v) antifoam A (Sigma) and 0.000 1 % (w/v) thimerosal
[45]. Membranes were incubated overnight in monospecific polyclonal antiserum
to human erythrocyte CD59 diluted in the blocking buffer. Membranes were
washed and incubated with peroxidase-conjugated secondary antiserum. Antibody
reactivity was visualized using 3 mM (wIv) chloronapthol (Sigma), 0.015 % (vIv)
H202,

16.7 % (vIv) methanol in tris-buffered saline (TBS) pH 7.4.

Immunofluorescence microscopy of Naea:leria amoebae

Trophozoites of pathogenic and nonpathogenic Naegleria amoebae were
placed on

12

mm round cover glasses and allowed to attach at 37 ° C.

NHS

diluted in HBSS was added to the cover glasses and allowed to incubate for 15
min to 1 h at 37 ° C. Following incubation, the cover glasses were removed and
extensively washed to remove unbound serum proteins. Cover glasses containing
serum-treated

amoebae were

fixed with

paraformaldehyde for 2 h at 37 ° C.

warm

(37 ° C)

0.25 %

(w/v)

Following fixation, cover glasses were

removed from the paraformaldehyde and allowed to air dry overnight. Cover
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glasses were rehydrated with 1 M PBS pH 7.2 and blocked with 0. 1 % bovine
serum albumin (BSA). Cover glasses were stained with either affinity-purified
rabbit polyclonal antiserum to human CD59 or rabbit polyclonal antiserum specific
for human complement proteins comprising the membrane attack complex (C5b
C9) (CaIBiochem). Fluorescein isothiocyanate-Iabeled goat anti-rabbit IgG
antiserum (Sigma) was used to visualize antibody reactivity. Cover glasses were
mounted on glass slides and viewed by fluorescence microscopy with an Olympus
BH-2 microscope.

Immunoprecipitation of amoebic Iysates using

CD59

antiserum

Pathogenic and nonpathogenic Naegleria were radiolabeled with 100J,£Ci/ml
of Tran[ 35S]label (methionine:cysteine) in Cline medium. Amoebae were washed
in HBSS and cell pellets were treated with 1 ml of lysis buffer [50 mM tris-HCI
pH 7.4, 0.5 % (v/v) nonidet P40, 0. 15 M NaCI, 0.02% (w/v) NaN3 , 5 mM EDTA,
0. 1 mM PMSF] for 2 h at 4 " C with gentle agitation.

Incorporation of [35S]

methionine:cysteine into newly synthesized proteins was determined by TCA
precipitation using Skatron filters (Skatron, Inc., Sterling, VA).

Aliquots of

radiolabeled cell lysates containing a constant number of TCA precipitable counts

(5

x

"
106) were incubated with 25 J,£g of CD59 antiserum at 4 C for

16

h.

Following incubation, a two-fold excess of a 50% (wIv) protein A Sepharose bead
suspension was added to the mixture and the mixture was incubated for an
additional 2 h at 4 " C. All incubations were performed with gentle agitation. The
sepharose beads were washed twice each with lysis buffer, with PBS containing
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0.05 % sodium azide and with 0. 1 % SDS. The washed beads were combined with
50j.LI of 2X sample solubilization buffer [0. 125 M tris-CI, pH 6.8, 4% SDS, 20%
glycerol, 0.05% (w/v) bromophenol blue] and heated to lOO ° C for 5 min. The
sepharose beads were pelleted by centrifugation and the supernatant fluid
separated on a 15% SDS-PAGE. Gels were fixed in 40% methanol/l0% acetic
acid, treated with EN3HANCE autoradiography enhancer (NEN Research
Products, Boston, MA), dried and exposed to film for 14 d at -70 ° C.

Generation of polyclonal antiserum to Nael:leria-specitic proteins in mice

PolycIonal antibodies to specific proteins from highly-pathogenic N. lowlen
were prepared in B6C3F l mice. Initially, mice were bled from the lateral tail vein
to obtain pre-immune serum. Lysates from highly-pathogenic N. lowlen were
separated by SDS-PAGE and stained with Coomassie blue to identify specific
bands of interest. Specific protein bands were excised from the acrylamide gel
and equilibrated in PBS for 2 h with gentle agitation.

Gel slices containing

protein were homogenized by passage through an 18 gauge needle, aliquoted into
equal volumes of PBS and stored at _70 ° C.

Mice were inoculated

intraperitoneally with protein-containing homogenized gel slices emulsified in an
equal volume of Freund's complete (50%) and incomplete (50%) adjuvant. After
a three week rest period, mice were given a booster injection. One week later,
blood was collected from the tail vein. The blood was allowed to clot at 4 ° C.
The serum was removed and stored at _70 ° C.
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Effect of antibody on susceptibility of Nae�leria to complement lysis

NaegZeria amoebae grown in Cline medium were radiolabeled with 50J,.LCi
of eH]uridine for 24 h. Amoebae were harvested by centrifugation and washed
in HBSS. Amoebae (1 x lOS) were incubated in the presence or absence of
polyclonal antiserum (rabbit antiserum to human CD59 or mouse antiserum to N.
JowZeri-specific proteins) for 1 h at 4 ° C. Following incubation, NHS diluted in
HBSS was added and the mixture was incubated for 1 h at 37 ° C. Supernatant
fluid and pellets were harvested and the CPM in each determined as described in
the amoebicidal assay. The percent specific release of radiolabel was determined
and used as an index of lysis. Pre-immune antiserum (rabbit or mouse) was used
to assess whether the antiserum was complement fixing for NaegZeria amoebae.

Northern analysis of Nae�leria amoebae

Preparation of E. coli competent cells:

E.

coli (DH5a) were grown to an

OD600 of 0.4. Bacteria ( 1.0 ml) were aliquoted and placed into microfuge tubes.
Bacteria were pelleted by centrifugation at 10,000 rpm (6000 x g) for 5 min.
Pellets were suspended in 100J,.LI of TSS solution [0.5 g tryptone, 0.25 g yeast
extract, 0.5 g NaCI, 5 g polyethyleneglycol (PEG) MW 8000 pH 6.5, 0.5
dimethylsulfoxide (DMSO), 0.2

ml

rnl

MgCI2] and stored at _70 ° C for 2-3 months.

Transformation of competent cells: Competent cells were incubated with
O.4J,.Lg of plasmid DNA [pUC19-CD59 or pBR322-GPD] on ice for 30 min. One
milliliter of SOC medium (2% bacto-tryptone, 0.5 % yeast extract, 10 mM NaCI,
2.5 mM KCI, 10 mM MgCI2, 10 mM MgS04, 20 mM glucose) was added and the
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mixture incubated at 37 ° C with shaking 200 rpm for 1-2 h. The cells were plated
onto antibiotic selective LB plates [ampicillin for pUCI9-CD59; tetracycline for
pBR322-GPD] containing 1 % (wIv) tryptone, 0.5% (wIv) yeast extract, 0.5%
(wIv) NaCI, 1 % (wIv) agar and l00J,£g/rnl ampicillin to select for transforrnants.
Plates were inverted and incubated overnight at 37 ° C. LB broth containing 1 %
(wIv) tryptone, 0.5% (wIv) yeast extract, 0.5% (wIv) NaCI and appropriate
antibiotics was inoculated with a single transforrnant colony and incubated for 5-7
h at 37 ° C, 200 rpm to obtain a saturated culture. Saturated cultures (1 ml) were
inoculated into 100 rnl of antibiotic selective LB broth and incubated overnight at
37 ° C, 200 rpm. Cells were harvested by centrifugation at 6000 x g for 15 min at
4 ° C. Pellets were lysed and plasmid DNA isolated using the Quiagen plasmid
DNA isolation kit as described by the manufacturer (Quiagen, Chatsworth, CA).
RNA isolation: Pathogenic and nonpathogenic Naegleria amoebae were
grown to confluency in 150 cm2 plastic tissue culture flasks (Nunc) in Cline
medium. Amoebae were gently rinsed with sterile PBS pH 7.4 to remove traces
of growth medium. Amoebae were lysed with 7.2 rnl of GT buffer consisting of
4 M guanidine isothiocyanate, 10 mM tris pH 7.4, 7% (vIv) B-mercaptoethanol in
diethylpyrocarbonate (DEPC)-treated water followed by the addition of SOOJ,£1 of

20% sarcosyl solution. Samples were passed through a 23 gauge needle and
placed into a 16 x 76 mm quick seal centrifuge tube (Beckman). Samples were
underlayed with CsCI (5.7 M CsCI, 10 mM (w/v) EDTA pH 7.4 in DEPC-treated
water) and the tubes sealed. Tubes were centrifuged in a Ti50 fixed angle rotor
at 40K for 16-20 h at IS ° c.

Tubes were immediately removed and the
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supernatant fluid discarded. Pellets were rinsed with room temperature 100%
ethanol and suspended in DEPC-treated sterile water. The mixture was diluted
with sodium acetate pH S.O to a final concentration 0.3 M. RNA was precipitated
with two volumes of ice-cold 9S- 1OO% ethanol and incubation at _70 ° C overnight.
RNA was pelleted by centrifugation in a microfuge (Costar, Cambridge, MA) at
4 ° C for S min. Pellets were air dried and suspended in DEPC-treated water. The
concentration of RNA was determined by optical density at 260/280.
RNA electrophoresis:

RNA was subjected to

1 % agarose gel

electrophoresis (1 % agarose, IX MOPS, 3 M sodium acetate, O.S M EDTA pH
7.4, 0. 18% formaldehyde) at 30V overnight with circulation. RNA (kB) markers
(Gibco-Bethesda Research Laboratories, Gaithersburg, MD) were separated by
electrophoresis to allow for RNA size determination. The quality and equivalent
loading of RNA was evaluated by ethidium bromide staining.

Gels were

equilibrated in 20 X SSC (3M NaCI, O.3M N�C6H504 or sodium citrate) for 20
min and the purified RNA transferred to QiaBRANE O.4SJ,.£m nitrocellulose
membranes (Qiagen) by capillary transfer.

RNA was crosslinked to the

nitrocellulose membranes using a UV Stratalinker (Stratagene, LaJolla, CA).

Probes: The pUC19 plasmid vector containing the full length human CDS9
cDNA was provided by Dr. Alfred Bothwell (Yale Medical School, New Haven,

CT). The cDNA for CDS9 was isolated from a i.. gtlO cDNA library constructed
from the human myelogenous leukemia cell line K-S62. The clone was digested
with EcoR 1 [93].

The resulting fragments were separated by agarose gel

electrophoresis and the SOO bp fragment containing CDS9 cDNA was excised,
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eluted and purified. The pBR322 plasmid vector containing the glyceraldehyde
3-phosphate dehydrogenase (GPD) cDNA was digested with PstI [ 1 16].

The

fragments were separated by agarose gel electrophoresis and the 1.3 kB fragment
containing GPD cDNA was excised, eluted and purified. cDNA probes were 32 p_
labeled by nick-translation and used as probes for Northern blot analysis.
Radiolabelin� of DNA by nick-translation: Plasmid DNA (5JLg) containing
cDNA probe inserts was digested with restriction enzymes to separate the cDNA
inserts. Inserts were excised from the gel and the cDNA extracted using the
QIAEX gel extraction kit (Qiagen). Extracted DNA was radiolabeled with 32p_
dCfP (NEN) by Nick Translation using methods described by Gibco-BRL.
Radiolabeled DNA was separated from unincorporated nucleotide using NICK
columns (Pharmacia LKB Biotechnology, Piscataway, NJ) as described by the
manufacturer.
Hybridization conditions: Nitrocellulose membranes containing RNA were
incubated in prehybridization buffer [50% (vIv) formamide, 0. 1 % (wIv) BSA,
0. 1 % (w/v) Ficoll 400, 0. 1 % (w/v) polyvinyl-pyrrolidone 40, 0.005 % (v/v) SDS,
0.05 M NaHP04'

5X SSC, 0.025 %

(w/v)

yeast

RNA] for 3-4 h with gentle

agitation. Membranes were hybridized for 18 h at 22 ° C in hybridization buffer
containing prehybridization buffer, containing 5 % dextran sulfate and 1 x 106
cpm/ml of radiolabeled nick-translated probe with gentle agitation. Membranes
were washed in 2X SSC/0.2% SDS (4X, 5 min each), in 2X SSC/0.2% SDS ( IX,
30-40 min), and in 0.5X SSC/0.2% SDS ( IX, 20 min). All washes were performed
°
at 37 C. Membranes were allowed to dry and exposed to diagnostic film at _70 ° C
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for 48 h. The stringency was increased by increasing the temperature during the
prehybridization step, the hybridization step and the wash steps. Membrane
bound probes were stripped by incubating at 95 ° C for 5 min in O.OlX SSC/0.01 %
SDS and rehybridized with 32P-Iabeled GPD cDNA to confirm and quantitate
equivalant loading of RNA in each lane.

Nom arski optics microscopy of N. fowleri amoebae

Trophozoites of pathogenic N. fowleri amoebae were placed onto 12
round cover glasses and allowed to attach at 37 ° C for 2 h.

mm

Cover glasses

containing amoebae were incubated for 15 to 30 min with diluted NHS. Following
incubation, cover glasses containing amoebae were fixed overnight in 2.5 %
glutaraldehyde (Sigma) buffered with 0. 1 M sodium cacodylate (pH 7.2) for 2 h
at 37 ° C. Cover glasses were mounted on glass slides and viewed with an Olympus
BH-2 microscope with Nomarski optics.

Electron microscopy of N. fowleri amoebae

Scanning electron microscopy (SEM): Trophozoites of Naegleria amoebae
grown in Nelson medium or Cline medium were placed onto 12
glasses in growth medium and allowed to attach at 37 ° C for

1

mm

round cover

h. Cover glasses

containing amoebae were incubated at 37 ° C in diluted NHS or buffer for 15-60
min in an atmosphere of 5 % CO2 . Cover glasses were fixed with warm (37 ° C)
2.5 % glutaraldehyde-buffered with 0. 1 M sodium cacodylate (pH 7.2) for 2 h at
37 ° c.

After

a 2 h incubation at 37 ° C, the cover glasses were incubated overnight

37
at 4 ° C. The samples were washed with 0. 1 M cacodylate buffre and post-fixed for
1 h with 1 % osmium tetroxide in 0. 1 M sodium cacodylate buffer pH 7.2. Cover
glasses were washed twice with cacodylate buffer and dehydrated in
ethanol washes (30%, 50%, 70%, 90% and 100%).

a

series of

The cover glasses were

subjected to critical point drying and coated with gold. Cells were viewed with a
JEOL scanning electron microscopy operating at 15 kV.
Transmission electron microscopy (TEM):

Trophozoites of Naegleria

amoebae grown in Nelson medium or Cline medium incubated in NHS or buffer
were pelleted by centrifugation and fixed with warm 2.5 % glutaraldehyde in 0. 1
M sodium cacodylate buffer (pH 7.2). Cells were fixed overnight at 4 ° C and
processed for TEM as previously described [62]. The amoebae were viewed with
a Zeiss transmission electron microscope operating at 65 kV.

Quantitation of complement protein C9 binding to the surface of N. fowleri

l
Complement component C9 was radiolabeled with 500J,LCi of Na 25 I
(Amersham, Arlington Heights, IL) using Iodobeads (Pierce) as described by the
manufacturer. Unbound iodine

was

removed by Excellulose GF-5 Desalting

chromatography (Pierce). Specific binding of radiolabeled C9 to highly-pathogenic
N.

Jowleri amoebae was determined using a modification of the procedure

described by Joiner [48, 49]. Briefly, N. Jowleri were harvested by centrifugation
and washed twice in HBSS. Amoebae were counted using a hemacytometer and
suspended at a concentration of 1

x

106 amoebae per 100J,L1. Amoebae ( 1

x

1 06 )

were added to silicon-coated tubes (Costar, Cambridge, MA) and pelle ted by
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centrifugation at 10,000 rpm (6000

x

g) for 10 min.

Supernatant fluid

was

removed and specific binding of 1 25I_C9 was determined by incubating N. Jowleri
LEEmpCl with C9-deficient NHS reconstituted with 1 25I_C9 (0.6J,£g) for 30 min.
Nonspecific binding of 1 25I-C9 to amoebae was measured by incubating amoebae
in heat-treated (50 ° C for 20 min) containing 125I-C9 (0.6J,£g). Following
incubation, the solution was layered onto an oil cushion and centrifuged at 6000
x

g for 6 min. The supernatant fluid was harvested and the tubes containing the

cellular pellet and oil cushion were collected and the cell-associated radioactivity
present in each determined in a gamma counter. Percent specific binding ( % SB)
was calculated using the following formula:

CPM pellet
% SB

=

specific bi n di n g

- CPM pellet

nonspecific bindi n g

------

x

100%

total input CPM

Quantitative and visual analysis of C9 binding to N. fowleri and release by
vesiculation

N.

Jowleri amoebae (1

x

106) were harvested and placed into a series of

silicon-coated microfuge tubes in triplicate.

Pellets were generated by

centrifugation and amoebae suspended in a 1:8 dilution of C9-deficient NHS
reconstituted with 125I_C9. Nonspecific binding was determined by incubating
amoebae in heat-treated (50 ° C for 20 min) NHS reconstituted with 125I_C9.
Tubes were incubated for various time intervals from 15 to 120 min at 37 ° C with
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gentle agitation to prevent settling of the amoebae. Following incubation, intact
amoebae and released membrane vesicles were separated using a modification of
previously described procedures for isolating released membrane vesicles [ 10, 128] .
First, the mixture was centrifuged at 5000 rpm ( 1000 x g) for 10 sec to pellet the
amoebae (pellet 1). The remaining supernatant fluid was gently removed with a
microcapillary pipet tip and placed in a silicon-coated tube.
centrifuged at 10,000 rpm (6000

x

The tube was

g) for 20 min to pellet membrane vesicles

present in the supernatant (pellet 2). The cpm of radioactivity associated with
pellet 1, pellet 2 and the final supernatant were determined using a Packard
Gamma Counter (Packard, Downers Grove, IL). The percent C9 cpm bound to
pellet 1 and pellet 2 was determined using the following formula:
CPM specific
% C9 cpm (pellet 1 )

=

(pellet

1 ) - CPM nonspecific

(pe llet

1)

---

CPM

(pellet

1 ) + CPM

x

100%

(pellet 2)

Nomarski optics microscopy was performed to verify the contents of each
pellet. Briefly, pellets and supernatant fluid were generated as described. Pellets
were subjected to fixation with 50J,.£1 of 2.5 % glutaraldehyde in 0. 1 M cacodylate
buffer. Pellets were suspended in glutaraldehyde and placed onto glass slides. The
suspension was covered with a round cover glass and sealed to preserve the
sample. Supernatant fluid was mixed 1 : 1 with 4% glutaraldehyde, mounted on a
glass slide and sealed. Parallel samples were prepared as described in the absence
of glutaraldehyde fixation to determine the status of each sample following
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prolonged incubation periods (2-4 h) of the amoebae and membrane vesicles in
NHS.

Cytocbalasin treatment of NaeKleria amoebae

Log-phase cultures of [3H]-uridine-labeled pathogenic and nonpathogenic
Naegleria were incubated with either cytochalasin D or cytochalasin B (20J,.£g/ml)
suspended in growth medium for 2 h at 37 ° C or 30 ° C. Following treatment, the
amoebae were harvested and incubated in NGPC for 1 h at 37 ° C in the presence
or absence of drug. The percent specific release of radiolabel from the amoebae
was determined using the amoebicidal assay.

RESULTS

Growth Medium Studies

Pathogenic N. Jowleri amoebae were maintained in axenic culture in either
Nelson medium or Cline medium. Table 1 lists the ingredients in Nelson medium
and Cline medium.

To assess whether medium composition affects the growth

of pathogenic N. Jowleri, growth curves of both weakly-pathogenic LEE (Figure
2A) and highly-pathogenic LEEmpC1 (Figure 2B) grown in Nelson or Cline
medium were generated. Growth curves for N. Jowleri LEE and LEEmpC1
amoebae grown in the same medium were similar. The growth of both LEE and
LEEmpC1 in Cline medium exceeded their growth in Nelson medium by 10 fold.
To determine whether growth conditions modulate complement resistance
of pathogenic N. Jowleri LEEmpC1, amoebae obtained from infected mouse brain
were cultured axenically in vitro

in

two different growth media, Nelson medium

or Cline medium. In vitro cultured amoebae were radiolabeled with [ 3H]uridine
followed by incubation in NGPC to determine their susceptibility to complement
lysis. Highly-pathogenic N. Jowleri LEEmpC1 amoebae grown axenically for 30
days in Cline medium remained resistant to lysis by complement (Table 2). In
contrast, axenic growth of the amoebae in Nelson medium for 30 days resulted in
41

42

Table 1 : Composition of growth media for Naegleria amoebae.
Media (% composition)a
Ingredients

Nelson

Cline

Liver digest

0. 1%

0.55 %

D-( + )-glucose

0. 1 %

0.3 %

Bacto-peptone

0.5 %

Yeast extract

0.25 %

Bovine heminb

0. 1 %

Donor calf serumb

2.0%

1.0%

Page amoeba saline

+

+

a Percentages were calculated on the basis of weight per volume (wIv).
b

Percentages for donor calf serum and bovine hemin were calculated

basis of volume per volume (vIv).

on

the
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Figure 2: Growth of two strains of Naeglena Jowlen amoebae in different axenic
media. The LEE strain was grown in either Cline medium or Nelson medium in
2
75 cm tissue culture flasks at 37 ° C prior to growth in a gyrotory shaker. The
LEEmp strain was passaged through mice and the amoebae were isolated from
brain tissue by placing infected brain in tissue culture flasks containing either
Cline medium or Nelson medium for 5 d prior to the growth studies. (A) LEE
strain grown in Cline medium (solid line) or Nelson medium (hatched line) for 5
°
d at 37 C in a gyrotory shaker. (B) LEEmpCl grown in Cline medium (solid line)
or Nelson medium (hatched line) for 5 d at 37 ° C in a gyrotory shaker.
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an increased susceptibility to complement lysis (Table 2). The susceptibility of
N. fowleri amoebae to complement-mediated lysis differed significantly depending
on the medium in which the amoebae were grown and the number of days the
amoebae were maintained in axenic culture.
To determine whether modulation of susceptibility to complement was a
result of differences in the ability of the amoebae to activate the ACP of
complement, the AP-complement hemolytic (AP-CHso) units remaining in NHS
following incubation with N. fowleri LEEmpC1 were measured. Pathogenic N.
fowleri grown axenically in Nelson medium or Cline medium activate the ACP

equally well as measured by the ability of the amoebae to deplete AP-CHso units
equally from NHS (Table 2).
To determine the time point during axenic cultivation that growth medium
modulates the ability of highly-pathogenic amoebae to resist complement lysis,
amoebae were inoculated intranasally into B6C3Fl mice.

Four days post

inoculation, the brains from infected mice were harvested and placed into tissue
culture flasks containing either Nelson medium or Cline medium. The amoebae
were allowed to migrate from the brain for 6-12 h followed by removal of the
residual brain tissue and addition of fresh growth medium. The susceptibility of
the amoebae to complement lysis was determined at different time intervals
during axenic culture in vitro from 1 to 30 days (Figure 3). Highly-pathogenic
LEEmpC1 amoebae grown in Nelson medium were resistant to complement
mediated lysis when grown in axenic culture for approximately 12 days. In vitro
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Table 2: Susceptibility of highly-pathogenic Naeglena Jowlen to complement lysis
and the AP-CHso units remaining following growth in different media.
N. Jowlen
amoebae

#

Days
in vitro

Growth media

% Lysis8

% of Complement
units depletedb

LEEmpC1

8
8

Cline
Nelson

25.8
24.9

±

1.7
3.0

27.9 %
30.8 %

LEEmpC1

30
30

Cline
Nelson

22.4
50.2

±

1.8
2.5c

47.8 %
35.8 %

±

±

8 [ 3H]uridine labeled N. Jowlen LEEmpC1 amoebae grown in either Nelson
medium or Cline medium for 8 days or greater than 30 days were incubated with
NHS ( 1 :4) for 1 h at 37 ° C. Each value represents the percent specific release of
radiolabel ± standard error of the mean from amoebae from a representative
experiment.
b NHS was incubated with N. Jowlen LEEmpC1 for 1 h at 37 ° C. Each value
represents the percent AP-CHso units depleted from NHS following incubation
with N. Jowlen amoebae from a representative experiment. The initial hemolytic
activity of the serum (201 units/ml) was used to calculate the percent AP-CHso
units depleted.
c p < 0.01
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Figure 3: Susceptibility of Naegleria fowleri amoebae to complement-mediated
lysis after continuous culture in vitro.N. fowleri LEEmpC1 amoebae were grown
axenically in either Nelson medium or Cline medium for a minimum of 30 days
following removal from mouse brain. At various time points amoebae were
radiolabeled with [3H]uridine and incubated with NGPC ( 1 :2) for 1 h at 37 ° C.
Each value represents the percent specific release of radiolabel ± standard error
of the mean from amoebae from a representative experiment.
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axenic culture of amoebae in Nelson medium for greater than 12 days resulted in
a statistically significant increase in the susceptibility of the amoebae to
complement lysis. In contrast, highly-pathogenic LEEmpC1 amoebae grown in
Cline medium remained resistant to complement lysis following in vitro cultivation
for time periods greater than 30 days (Figure 3).
To determine whether the inability of pathogenic

N.

fowleri to resist

complement lysis when grown in Nelson medium parallels a loss in virulence, 8week old B6C3Fl mice were inoculated intranasally with 1 x 1 <f highly-pathogenic
N.

fowleri LEEmpC1 amoebae grown axenically for either 10 days or 30 days in

either Nelson medium or Cline medium.

The percent mortality of mice

inoculated with amoebae was determined and used as an index of virulence. A
100% mortality was observed in mice inoculated intranasally with LEEmpC1
amoebae which had been cultured axenically in either Nelson or Cline medium
for 10 days. A 100% mortality was observed in mice inoculated with LEEmpC1
amoebae grown axenically in Cline medium for 30 days. In contrast, a 40%
mortality rate was observed in mice inoculated intranasally with mouse-passaged
LEEmpC1 amoebae grown axenically in Nelson medium for 30 days (Table 3).
No amoebae were identified from the brains of mice surviving after inoculation
with

N.

fowleri amoebae grown in Nelson medium.

The ability of growth medium supplemented with bovine hemin to
modulate complement resistance in vitro was evaluated.

N. fowleri amoebae

grown

axenically for a minimum of 20 days in Nelson medium or Cline medium were
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Table 3 : Virulence of Naegleria Jowleri amoebae after growth in Nelson medium
or Cline mediuma•
N.

Jowleri

LEEmpCl
day lOb
LEEmpCl
day 30c

Growth medium

Inoculum

Nelson
Cline

1 x l(f
l x l <f

100
100

8.6
1 1.8

Nelson
Cline

4
1 x 10
l x l <f

40
100

18.5
10.3

% Mortality Avg. days to death

a Eight-week old B6C3Fl mice were inoculated intranasally with highly-pathogenic
LEEmpCl amoebae grown axenically in either Nelson medium or Cline
medium for 10 d or 30 d (n = 5). Data are represented in average days to
death.The number of deaths from a representative experiment was recorded for
30 d. Similar data were obtained each time the experiment was repeated.
b N. Jowleri LEEmpCl grown axenically for 10 d in Nelson medium (complement
resistant) or Cline medium (complement-resistant).
e N. Jowleri LEEmpCl grown axenically for 30 d in Nelson medium (complement
sensitive) or Cline medium (complement-resistant).

N. Jowleri
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switched to growth medium in the absence or presence of 0. 1 % supplemental
bovine hemin for 4 days (Figure 4).

The susceptibility of the amoebae to

complement lysis was measured using the amoebicidal assay. Growth of N. Jowlen
amoebae in medium supplemented with 0. 1 % bovine hemin increased the ability
of the amoebae to resist complement lysis when compared to amoebae grown in
medium lacking supplemental bovine hemin. However, the ability of N. Jowlen
amoebae to resist complement lysis when grown in hemin-supplemented Nelson
medium was less than that of amoebae grown in hemin-supplemented Cline
medium. The use of higher concentrations of supplemental bovine hemin (0.2%
or 0.3 %) was toxic to the amoebae.
To determine whether the susceptibility of highly-pathogenic LEEmpC 1
amoebae t o complement when maintained in Nelson medium could b e modulated
by changes in growth medium, amoebae grown in Nelson medium were shifted to
growth in Cline medium for 2 h prior to the addition of serum complement.
Susceptibility of N. Jowlen LEEmpC1 to complement lysis when grown in Nelson
medium can be decreased by incubating the amoebae in Cline medium for 2 h
prior to the addition of serum complement (NGPC) (Figure 5).

In parallel

experiments, pathogenic LEEmpC1 amoebae grown in Nelson medium for 20 days
were pretreated with 5 ILg/ml cycloheximide for 4 h, to inhibit protein synthesis.
Following pretreatment with cycloheximide, the amoebae were shifted to Cline
medium containing 5 ILg/ml cycloheximide for 2 h and the susceptibility of the
amoebae to lysis by complement was determined. Inhibition of protein synthesis
for 6 h in LEEmpC1 amoebae grown in Nelson medium blocked the ability of the
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The effect of hemin on susceptibility of Naegleria fowleri to
Figure 4 :
complement-mediated lysis. 3 [H]uridine-Iabeled N. fowleri LEEmpC 1 grown
axenically in Nelson medium or Cline medium for a minimum of 20 d were
switched to growth in medium in the absence or presence of supplemental bovine
hemin (0. 1 %) for 4 d. Following incubation, amoebae were incubated with NGPC
( 1 :2). Each value represents the percent specific release of radiolabel ± standard
error of the mean from amoebae from a representative experiment.
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Figure 5: The effect of growth media alterations on susceptibility of Naegleria
Jowleri to complement-mediated lysis. [3H]uridine-labeled N. Jowleri LEEmpC 1
were grown in Nelson o r Cline medium for a minimum o f 2 0 d . Parallel cultures
of amoebae grown in Nelson medium were shifted to growth in Cline medium for
2 h or 4 h followed by incubation with NGPC ( 1 :2). Each value represents the
percent specific release of radiolabel ± standard error of the mean from amoebae
from a representative experiment.
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amoebae to become resistant to complement-mediated lysis following a shift to
growth in Cline medium (Figure 6). Cycloheximide-treated control amoebae
incubated in NHS demonstrated similar susceptibility to complement lysis when
compared to untreated control amoebae incubated in NHS (data not shown).
Metabolic-labeling of amoebae with Tran[35 S]label (methionine:cysteine)
was used to identify proteins differentially expressed in N. Jowleri following a shift
from growth in Nelson medium to growth in Cline medium. Amoebae maintained
in Nelson medium were shifted to growth in Cline medium in the presence of
[35 S]methionine:cysteine radiolabel for 2 hr. Lysates were generated and the
radiolabeled proteins separated by SDS-PAGE.
subjected to autoradiography.

The gels were dried and

Analysis of [35 S]-labeled polypeptides using a

Shimadzu image analyzer and computer integration programs allowed for the
identification of polypeptides of approximate molecular mass 95, 65, 62, 50, 49, 44,
and 28 kDa whose synthesis was induced in pathogenic N. Jowleri LEEmpCl in
response to a shift in growth from Nelson medium to Cline medium (Figure 7).
Polypeptides induced by shifts in media (lane 2) are indicated by arrows and the
bands numbered consecutively from

1

(top) to 6 (bottom).

Polypeptides

synthesized by amoebae in response to a shift from Nelson to Cline medium were
absent from lysates generated from a 2 h [35 S]-labeling of LEEmpCl amoebae
maintained throughout the experimental procedure in Nelson medium only. Table
4 lists the relative molecular mass and density volume units corresponding to
polypeptides detected following media alterations. Relative density volume values
have been standardized to background density values. The densities of the
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Figure 6: The effect of growth media alterations in the presence and absence of
cycloheximide on susceptibility of Naegleria fowleri to complement-mediated lysis.
N. fowleri LEEmpC1 grown in either Nelson medium or Cline medium for a
minimum of 20 days were radiolabeled with [3H]uridine for 24 h. Radiolabeled
amoebae were grown in medium in the presence or absence of 5J,Lg/ml
cycloheximide (CHX) for 4 h prior to incubation with NGPC ( 1 :2). Each value
represents the percent specific release of radiolabel ± standard error of the mean
from amoebae from a representative experiment.
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Figure 7: Autoradiographic analysis of Tran[ 35S]methionine:cysteine-labeled
Naegleria Jowleri LEEmpC1 subjected to media alteration. N. Jowleri LEEmpC 1
were grown in Nelson or Cline medium for a minimum of 20 days. Amoebae
were radiolabeled with Tran[35 S]label (methionine:cysteine) for 2 h. A parallel
culture of N. Jowleri grown in Nelson medium was shifted to growth in Cline
medium for 2 h in the presence of Tran[35 S]label. Whole cell lysates from N.
Jowleri grown continuously in either Cline or Nelson medium or N. Jowleri
subjected to a media shift were prepared and subjected to SDS-PAGE. The gels
·
were dried and exposed to film for 14 days at -70 C. Lanes: ( 1) LEEmpC 1
amoebae grown in Nelson medium; (2) LEEmpC1 amoebae shifted from growth
in Nelson medium to growth in Cline medium for 2 h; (3) LEEmpC1 amoebae
grown in Cline medium. Arrows (lane 2) indicate proteins induced following a
shift from growth in Nelson medium to growth in Cline medium (numbered 1-6).
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Table 4: Densitometric analysis of Naegleria Jowleri polypeptides expressed
following alterations in amoebic growth mediuma•
Band
1
2
3
4
5
6

#

Relative mol.
mass
95
65
62
49
44
28

kDa
kDa
kDa
& 50 kDa (doublet)
kDa
kDa

Relative density
units
7.3
9.8
5.7
3.9
5.6
13.7

% Control
expressionb
3 16 %
50 %
78 %
79 %
64 %
84 %

a N Jowleri LEEmpC1 amoebae grown in Nelson medium were shifted to growth
in Cline medium for 2 h at 37 ° C in the presence of Tran[ 35 S]label. Amoebic
lysates were generated and separated by SDS-PAGE. Gels were dried and
subjected to autoradiography. Polypeptides detected by autoradiography were
analyzed and compared using a Shimadzu scanner and integration programs.
b Percent control expression was determined by comparing the relative densities
of polypeptides induced in N Jowleri amoebae following a shift in growth from
Nelson medium to Cline medium (Figure 6, lane 2) with the relative densities of
the same polypeptides synthesized in amoebae grown in Cline medium (Figure 6,
lane 3).
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polypeptides (lane 2) were compared to the densities of the corresponding
(control) polypeptides from amoebae grown in Cline medium (lane 3) and the
percent of control expression was calculated.

Protein analysis studies

Three strains of Naegleria amoebae grown in Cline medium were treated
with

either

phosphatidylinositol-specific

phospholipase

C

(PIPLC)

or

endoglycosidase H (endo H). An in vitro lytic assay was used to confirm that
enzymatic

removal

of

surface-associated

membrane

components

from

complement-resistant amoebae enhanced their susceptibility to complement
mediated lysis. Treatment of complement-resistant N. fowleri LEEmpC l with
PIPLC or endo H increased the susceptibility of highly-pathogenic amoebae to

lysis by complement. In contrast, neither enzymatic treatment had a significant
effect on the susceptibility of weakly pathogenic or nonpathogenic Naegleria
amoebae to the lytic effects of complement (Figure 8).
To assess the role of glycoproteins in resistance of N. fowleri to
complement-mediated lysis,

Naegleria

amoebae were grown in Cline medium

containing various concentrations of tunicamycin for 18 h prior to the addition of
NGPC. The susceptibility of highly-pathogenic and weakly -p ath ogenic N. fowleri

to lysis by complement increased in a dose-related manner following growth in
medium containing 2.0 or 3.0 J.£g/ml tunicamycin (Figure 9). In contrast, growth
of complement-sensitive, nonpathogenic N. gruberi amoebae in the presence of
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Figure 8: The effect of enzymatic treatment on lysis of Naegleria amoebae by
complement. [3H]uridine-Iabeled Naegleria amoebae (1 x lOS to 1 x 106 ) were
treated with 500mU jrnl of PIPLC for 1 h or 40mU of endoglycosidase H for 4 h
°
at 37 C. Following enzymatic treatment, amoebae were washed in HBSS and
°
incubated in NGPC ( 1 :2) for 1 h at 37 C. Values represent the percent specific
release of radiolabel ± standard error of the mean from a representative
experiment. Asterisks denote statistically significant differences (p ( 0.05 for
PIPLC; P ( 0.2 for Endo H).

64

A

100

80

• None
� PIPLC

60

40

20

o

LEEmpCl

LEE

EGB

A m o e b ae

B

100

80

.�

fI)

�

• None
� Endo H

60

�

�

40

20

o

LEEmpC l

LEE

Amoebae

EGB

65

Figure 9: The effect of tunicamycin on the susceptibility of Naegleria amoebae to
complement-mediated lysis. [3H]uridine-labeled Naegleria spp. were grown in
Cline medium the presence of 2J.Lg/ml or 3J.Lg/ml of tunicamycin for 18 hours at
°
37 ° C (N. Jowleri) or at 30 C (N. gruberi). Tunicamycin-treated Naegleria were
washed with HBSS followed by incubation in NGPC ( 1 :2) for 1 h at 37 ° C. Values
represent the percent specific release of radiolabel ± standard error of the mean
from a representative experiment. Asterisks denote statistically significant
differences (p ( 0.01 for 2J.Lg/ml tunicamycin; p ( 0.001 for 3J.Lg/ml tunicamycin).
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tunicamycin did not alter the susceptibility of the amoebae to complement
mediated lysis. To ensure that tunicamycin was not inhibiting protein synthesis,
Naegleria spp. were radiolabeled with [35S]methionine in the presence or absence

of tunicamycin. Inhibition of protein synthesis was determined by comparing the
amount of [35S]methionine incorporated into tunicamycin-treated amoebae to the
amount incorporated into untreated control amoebae. Treatment of amoebae
with concentrations of 2J..£ g/ml or 3J..£ g/ml of tunicamycin for 18 h resulted in less
than 6% inhibition of protein synthesis in N. Jowleri LEEmpC1 or LEE amoebae
when compared to untreated control amoebae. Treatment of N. Jowleri amoebae
with higher concentrations (4J..£ g/ml) of tunicamycin or increased incubation
periods with the drug, inhibited protein synthesis by 24%.

In comparison,

nonpathogenic N. gruberi amoebae were more sensitive to tunicamycin treatment.
A minimal inhibition of protein synthesis ( 13%) occurred in the presence of

3J..£ g /ml of the drug. Higher concentrations of tunicamycin were found to be toxic
to nonpathogenic Naegleria amoebae.
To determine whether the effect of tunicamycin is reversible, [3H]uridine
labeled amoebae were treated with tunicamycin for 18 h followed by incubation

in tunicamycin-free medium for 24 h. Removal of tunicamycin from LEEmpC 1
and LEE amoebae and growth in tunicamycin-free medium for 24 h resulted in
recovery from drug treatment with an increased ability to resist complement
mediated damage when compared to the untreated control amoebae (Figure 10).
Treatment with tunicamycin and removal of the drug had no effect on the
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Figure 10: The effect of tunicamycin treatment followed by removal of the drug
on the susceptibility of Naegleria amoebae to complement-mediated lysis.
[3H]uridine-Iabeled Naegleria spp. were grown in the presence of 3J..1. g /ml of
tunicamycin for 18 hours at 37 ° C (N. Jowleri) or 30 ° C (N. gruberi). Parallel
cultures were treated with 3J..1. g/ml tunicamycin for 18 h followed by removal of
drug and incubation in tunicamycin-free medium for an additional 24 h prior to
assay. Following treatment amoebae were incubated with NGPC ( 1 :2) for 1 h at
37 ° C. Values represent the percent specific release of radiolabel ± standard error
of the mean from a representative experiment. Asterisks denote statistically
significant differences (p < 0 0 1 for LEEmpCl ; p < 0.00 1 for LEE).
.
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susceptibility of nonpathogenic N. gruberi amoebae to complement.
To examine the effect of tunicamycin treatment on protein expression in
pathogenic and nonpathogenic amoebae, we employed [35 S]methionine metabolic
labeling. Amoebae were radiolabeled in either the presence or absence of 3}.£g/ml
of tunicamycin. Cell lysates were prepared and analyzed using SDS-PAGE and
autoradiography. The autoradiograms of both strains of N. Jowleri (LEEmpC 1 and
LEE) amoebae treated with tunicamycin in the presence of [35 S]methionine
demonstrated an increase in the quantity or concentration of de novo synthesized
proteins following tunicamycin treatment when compared to untreated control
amoebae (Figure 1 1 A and 1 1 B). In contrast, an increased concentration of de
novo synthesized proteins was not detected in nonpathogenic N. gruberi amoebae

treated with tunicamycin (Figure 1 1C). In addition to an accumulation of proteins
within the amoebae, the synthesis of several glycoproteins in pathogenic
LEEmpC1 and LEE amoebae with relative molecular mass ranging from 18 kDa
to 73 kDa were decreased or altered following tunicamycin treatment (Figure 1 1).
In particular, proteins of relative molecular mass 182, 50, 39, 34, 32, 30, and 29
kDa were decreased or altered in both LEEmpC1 and LEE amoebae.
Autoradiograms of iodinated amoeba surface proteins from the highly
pathogenic N. Jowleri LEEmpC1 and weakly-pathogenic LEE detected proteins of
similar molecular mass between the two strains. Proteins of molecular mass 89,
60, 44, and 28 kD were identified in greater quantity in highly-pathogenic

LEEmpC1 strain of N. Jowleri (Figure 12). These proteins were either absent or
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Figure 1 1 : The effect of tunicamycin on newly synthesized Naegleria-specific
proteins. Autoradiographs of SDS-PAGE gels containing 25 IJ.g [ 35 S]methionine
labeled proteins of (A) N. Jowleri LEEmpCl ; (B) N. Jowleri LEE; and (C) N.
gruberi EG B amoebae were incubated in either the presence ( + ) or absence ( ) of
"
"
3lJ.g/ml of tunicamycin for 18 h at 37 C or 30 C. Arrows indicate proteins
showing altered expression following tunicamycin treatment.
-
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detected to a lesser extent by surface iodination in the weakly-pathogenic LEE
strain.

Few similarities in surface iodinated proteins were detected between

pathogenic and nonpathogenic amoebae. Trypan blue exclusion in conjunction
with phase contrast microscopy were used to determine whether amoebae were
viable after iodination.

Greater than 93% of the amoebae were viable as

determined by the exclusion of dye.
To further characterize the specific nature of these surface proteins, lysates
from surface iodinated amoebae were separated by SDS-PAGE, transferred to
nitrocellulose and stained using biotinylated lectins specific for either mannose
(Concanavalin A) or fucose (Ulex europaeus agglutinin I).

A comparison of

duplicate immunoblots stained with the two lectins indicated that Naegleria
proteins stain more intensely with Concanavalin A (Con A) as compared to
staining with Ulex europaeus agglutinin I (Figure 13). Although, Con A recognized
a number of glycoproteins in nonpathogenic N. gruberi amoebae, the molecular
mass of these glycoproteins differed from the glycoproteins recognized by Con A
in pathogenic strains of N. Jowleri.

Autoradiograms of the lectin-stained

irnmunoblots indicate that the four proteins identified in highly-pathogenic
LEEmpCl amoebae by surface iodination were glycoproteins and possessed
differences in the types of sugar residues associated with the proteins. The 89
kDa surface protein was recognized by Con A, suggesting that mannose residues
were associated with this protein. Surface proteins of molecular mass 60 and 28
kDa stained with Ulex europaeus agglutinin I, suggesting the presence of fucose
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Figure 12: Autoradiographic patterns of 1 25I-Iabeled cell surface proteins of
pathogenic and nonpathogenic Naegleria spp. separated by SDS-PAGE. Iodinated
cell surface proteins of N. Jowleri LEEmpC1, N. Jowleri LEE and N. gruberi EGB
amoebae were separated by SDS-PAGE and bands identified by Coomassie blue
staining (A). Gels were dried and exposed to film for 28 h (B). LEEmpC1
amoebae (lane 1); LEE amoebae (lane 2); EGB amoebae (lane 3). Arrows
indicate protein differences between LEEmpC1 and LEE amoebae.
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Figure 13: Biotinylated lectin stain of lysates from surface iodinated Naegleria spp.
Lysates of surface iodinated amoebae were separated by SDS-PAGE, transferred
to nitrocellulose and bands identified using (A) biotinylated Concanavalin A or
(B) biotinylated Ulex europaeus agglutinin I. LEEmpC1 amoebae (lane 1 ) ; LEE
amoebae (lane 2) ; EG B amoebae (lane 3). Arrows indicate lectin staining of bands
corresponding to surface iodinated proteins identified in highly-pathogenic
LEEmpC1 amoebae.
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residues.

The 44 kDa polypeptide was recognized by both Con A and Ulex

europaeus agglutinin I suggesting that both sugar residues were present on this

polypeptide. Arrows indicate the bands stained by each lectin which correspond
to the bands present in greater quantity in highly-pathogenic LEEmpC l amoebae
as detected by surface iodination.

CD59 studies

Polyclonal antiserum to CD59 from human erythrocytes was used to
identify proteins in N. Jowleri amoebae which cross-react with antiserum to this
human complement regulatory protein. Whole cell lysates from complement
resistant N. Jowleri, complement-sensitive N. gruberi and red blood cells (RBC)
were separated by SDS-PAGE under nonreducing conditions and the proteins
transferred to nitrocellulose membranes.

Antiserum to CD59 recognized

polypeptides of approximate molecular mass of 54, 46 and 42 kDa on
complement-resistant amoebae (Figure 14, lanes 1 & 2) which were not identified
on complement-sensitive N. gruberi amoebae (Figure 14, lane 3). Reactivity

of

anti-CD59 with human RBC lysates was used as a positive control for expression
of the

CD59,

18-20 kDa protein species (Figure 14, lane 4).

Immunofluorescence microscopy ofpathogenic and nonpathogenic Naegleria
stained with polyclonal antiserum against CD59 and FITC-conjugated goat anti
rabbit IgG demonstrated that pathogenic N. Jowleri stain positive for the presence
of CD59 and that fluorescence was localized to specific sites on the surface of the
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Figure 14: Western immunoblot analysis of proteins from Naegleria spp. stained
with antiserum to human CD59. Whole cell lysates from highly-pathogenic, N.
Jowleri LEEmpC1 (lane 1), weakly-pathogenic LEE (lane 2) and nonpathogenic
N. gruberi (lane 3) amoebae were separated by SDS-PAGE under non-reducing
conditions. Proteins were transferred to nitrocellulose membranes and stained
using antiserum to human CD59 and peroxidase conjugated goat anti-rabbit
antiserum. Lysates from human RBC ghosts were prepared and used as the
positive control (lane 4). N. Jowleri reactive proteins denoted by solid arrows.
Open arrow ( > ) indicates CD59 cross-reactive protein in human RBC.
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amoebae (Figure 15 B). A similar staining pattern was visualized with weakly
pathogenic N. Jowleri LEE stained with anti-CD59 (data not shown). In contrast,
immunofluorescence staining of nonpathogenic N. gruberi amoebae with anti-CD59
did not detect a significant amount of fluorescence staining above background
(Figure 15 D). CD59-specific staining intensity was shown to increase when the
amoebae were treated with NHS prior to membrane fIxation and staining (data
not shown). Minimal background staining was observed when amoebae were
incubated with FITC-conjugated goat anti-rabbit IgG alone (Figure 15 A and C).
Immunoprecipitation analysis was performed to determine whether the
CD59 cross-reacting polypeptides detected by western immunoblot analysis were
synthesized by N. Jowleri amoebae. Proteins from pathogenic and nonpathogenic
Naegleria amoebae were metabolically labeled with Tran[35 S]-methionine:cysteine.

Radiolabeled lysates were incubated with antiserum to CD59. Cross-reacting
antigens were immunoprecipitated using protein A sepharose beads, subjected to
non-reducing SDS-PAGE and analyzed by autoradiography. Immunoprecipitation
detected a 46 kDa protein species in highly-pathogenic and weakly-pathogenic N.
fowleri amoebae (Figure 16, lanes 1 & 2). This protein was not detected in in
nonpathogenic N. gruberi amoebae (Figure 16, lane 3).
The susceptibility of pathogenic and nonpathogenic Naegleria to
complement-mediated lysis in the presence of membrane-bound antibody to
human CD59 was performed to determine whether CD59 antibody was capable
of increasing the susceptibility of complement-resistant N. Jowleri to complement
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Figure 15: Immunofluorescence microscopy of Naegleria amoebae stained with
polyclonal antiserum to human CD59. Pathogenic (A & B) and nonpathogenic
(C & D) Naegleria amoebae were adhered to coverglasses and incubated in the
presence or absence of NHS followed by fixation with 0.25 % paraformaldehyde
°
for 2 h at 37 C. Coverslips were stained with polyclonal antiserum to CD59
followed by FITC-labeled goat anti-rabbit IgG antiserum and visualized by
immunofluorescence microscopy. Left panels (A & C) were stained with FITC
labeled goat anti-rabbit IgG antiserum only. Right panels (B & D) were stained
with rabbit anti-CD59 and FITC-Iabeled antiserum.
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Figure 16: Immunoprecipitation analysis of pathogenic and nonpathogenic
Naegleria using antiserum to human CD59. Naegleria amoebae were radiolabeled
with TranesS]label (methionine: cysteine ) for 24 h. Whole cell lysates were
generated and incubated with 25J,Lg of polyclonal antiserum to human CD59 for
18 h at 40 C. Antigen-antibody complexes were isolated with protein A-sepharose
beads. Immunoprecipitated proteins were separated by SDS-PAGE undernon
reducing conditions, the gels dried and subjected to autoradiography. Lanes ( 1 )
Highly-pathogenic N. fowleri LEEmpCl, (2) Weakly-pathogenic N. fowleri LEE,
(3) Nonpathogenic N. gruberi amoebae.
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lysis. The binding of anti-CD59 to the surface of complement-resistant amoebae
resulted in a modest increase in susceptibility of N. towleri to complement lysis
(Figure 17 A). Anti-CD59 treatment of nonpathogenic, complement-sensitive N.
gruberi amoebae did not alter susceptibility to complement lysis (data not shown).

Polyclonal mouse antiserum generated to CD59 cross-reacting N. lowleri proteins
were used to determine whether antiserum to N. lowleri proteins resulted in a
greater increase in susceptibility of complement-resistant amoebae to complement
lysis. The binding of antiserum to the 46 kDa polypeptide to N. lowleri amoebae
increased the susceptibility of the amoebae to complement, however the increase
was similar to that seen with anti-CD59 antiserum (Figure 17 B).
Northern analysis revealed the presence of an approximate 2000 bp RNA
species which hybridized to the CD59 probe in only pathogenic, complement
resistant N. lowleri amoebae (Figure 18, lanes 2 & 3).

Only background

hybridization was detected in RNA from nonpathogenic, complement-sensitive N.
gruberi amoebae (Figure 18, lane 1). Overexposure of northern blots revealed and

additional RNA species of approximately 900 bp (data not shown). Hybridization
of the same membrane with the GPD probe verified equivalent RNA loading in
each lane. Northern membranes were subjected to BetaGen scanner analysis to
quantitiate and compare the relative amounts of probe-bound radioactivity
associated with the RNA.

The amount of radioactive CD59 probe which

hybridized to RNA from pathogenic, complement resistant N. lowleri was
significantly greater than the background hybridization detected from

87

Figure 17: Effect of membrane bound antibody on susceptibility of highly
pathogenic N. Jowlen to complement-mediated lysis. [3 ]H-uridine labeled N.
Jowlen were incubated in the p resence of HBSS or polyclonal antiserum to CD59
(A) or GP46 (B) for 1 h at 4 C. Susceptibility to complement was measured by
°
incubation in NHS for 1 h at 37 C. Each value represents the percent specific
release of radiolabel ± standard error of the mean from amoebae from a
representative experiment.
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Figure 18: Northern blot analysis of CD59 expression. Total RNA (5J.1.g) from
pathogenic and nonpathogenic Naegleria amoebae w as separated by agarose gel
electrophoresis, transferred to nitrocellulose membranes and hybridized with
either a CD59 cDNA probe from the K562 cell line or a glyceraldehyde 3phosphate dehydrogenase (GPD) cDNA probe. Position of the 28S and 18S
ribosomal bands are indicated. Lanes (1) Nonpathogenic, complement-sensitive
N. gruberi, (2) Weakly-pathogenic N. Jowleri LEE, (3) Highly-pathogenic,
complement-resistant N. Jowleri LEEmpCl.
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nonpathogenic, complement-sensitive N. gruberi amoebae.

Vesiculation studies

Nomarski optics microscopy was used to visualize pathogenic, complementresistant N. Jowleri in the presence of NHS. Following a 15 min incubation in
serum complement, highly-pathogenic N. Jowleri change shape from amoeboid to
round with the formation of membrane blebs on the amoeba surface (Figure 19
A). After a 60 min incubation in serum complement, an increase in the number
of membrane blebs associated with the surface of the amoebae was observed
(Figure 19 B).

Membrane blebbing was not detected on the surface of

complement-sensitive, nonpathogenic N. gruberi after incubation in NHS. Neither
complement-resistant N. Jowleri nor complement-sensitive N. gruberi exhibited
membrane blebbing when incubated with HBSS alone (data not shown).
Scanning and transmission electron microscopy allowed for a closer analysis
of the amoeba surface following incubation in NHS.

Transmission electron

micrographs illustrate structures which appear to represent distinct membrane
extensions (vesicles) on the surface of the amoebae (Figure 20 A).

These

membrane vesicles do not appear to contain cellular organelles such as
mitochondria. Cellular organelles appear to reorganize within the cytoplasm of
the amoebae away from the forming membrane vesicle. NHS-treated amoebae
were processed for SEM. Scanning electron microscopy detected a significantly
larger number of membrane blebs on the amoebae in response to NHS treatment
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Figure 19: Nomarski optics microscopy of complement-resistant N. fowleri
amoebae incubated in normal human serum for 15 min (A) or 60 min (B). N.
fowleri LEEmpCl amoebae were incubated with NHS followed by fixation with
2.5% glutaraldehyde at 37 ° C. Arrows indicate membrane blebs or vesicles
detected by Nomarski optics microscopy.
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Figure 20: Transmission and scanning electron microscopy of N. Jowleri amoebae
incubated in NHS. Highly-pathogenic, complement-resistant N. Jowleri LEEmpC 1
amoebae were incubated in NHS diluted 1:8 followed by 2.5 % glutaraldehyde
fixation at 37·C in 0. 1 M cacodylate buffer pH 7.2. Fixed amoebae were
processed for either transmission (A) or scanning (B) electron microscopy.
Arrows indicate membrane vesicles formed in response to incubation in low
concentrations of serum complement.
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as compared to the membrane blebs detected by nomarski optics microscopy
(Figure 20 B). SEM of complement-resistant N. lowlen treated with different
concentrations of NHS demonstrated that membrane vesiculation was more
prominent when amoebae were incubated with NHS diluted 1:8 (Figure 21 C &
D). N. fowleri amoebae incubated in serum diluted 1 :2 showed less vesiculation

in comparison (Figures 2 1 A & B).
Binding assays were performed to determine whether highly-pathogenic N.
lowlen amoebae specifically bound complement component, C9, the final protein

required for MAC formation. Incubation of highly-pathogenic LEEmpCl with
NHS e25I-C9) resulted in a 2.7% specific binding of 125I-C9 to the amoebae or

approximately 2 x 106 molecules of C9 per amoeba. The specific binding was
quantitatively determined to be in excess of nonspecific 125I_C9 binding which
occurred in the presence of a 50-fold excess of cold C9 protein.
Due to the binding of C9 and formation of the MAC on the surface of
highly-pathogenic amoebae, indirect immunofluorescent staining was employed to
determine the location of the bound complement proteins (C5b-C9) and to
determine whether membrane attack complexes were present on the membrane
blebs.

Polyclonal rabbit antiserum specific for the detection of human

complement proteins (C5b-C9) comprising the intact MAC (anti-MAC) was used
in combination with FITC-conjugated goat anti-rabbit Ig and fluorescence
microscopy to visualize the location of the MAC.

Pathogenic, complement

resistant amoebae stained positive for the presence of the MAC following a 15
min incubation in diluted NHS. Positive fluorescent staining was concentrated at
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Figure 21 : Scanning electron microscopy of N. fowleri amoebae incubated in
different concentrations of NHS. Highly-pathogenic, complement-resistant N.
Jowlen amoebae were incubated in NHS diluted 1 :2 (A & C) or 1:8 (B & D) for
30 min followed by 2.5 % glutaraldehyde fixation. Arrows indicate membrane
vesicles in response to incubation in serum complement.
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the membrane surface of the amoebae confirming that membrane attack
complexes were present on the surface of the amoebae following initial exposure
to NHS diluted 1 :4 (Figure 22 A). In addition, a significant increase in the
intensity of fluorescent staining of the membrane blebs was observed when
amoebae were incubated for 60 min in NHS diluted 1 :4 (Figure 22 B). The
formation of large membrane vesicles or blebs was observed when N. [owleri were
incubated in the presence of less concentrated NHS ( 1 : 16) (Figure 22 C & D) or
1:8 (Figure 22 E & F). The appearance of membrane blebs was paralleled by a
shift in staining intensity from a diffuse halo-like staining of the entire plasma
membrane to a localized staining of large membrane blebs. Nomarski optics
microscopy of the same sample confirmed that the fluorescent staining
corresponded to the presence of membrane blebs on the surface of the amoeba
(Figure 22 D & F).
Differential centrifugation was combined with radioiodinated C9 binding
studies to separate intact amoebae from released membrane vesicles in order to
quantitate the kinetics of binding and release of the MAC (C5b- 1 2S I-C9) to
complement-resistant amoebae. Following initial exposure ( 15 min) of N. [owleri
to NHS containing 1 2SI_C9, 99.3 % of the membrane-bound 1 2SI_C9 cpm was
associated with pellet 1 which consisted of predominately intact amoebae, whereas
0.7% of the membrane-bound cpm was associated with pellet 2 containing
predominately released membrane vesicles (Figure 23). Following incubation of
amoebae with NHS for 30, 90, and 120 min, a time-dependent decrease in
membrane-bound cpm detected in pellet 1 (amoebae) was paralleled with an
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Figure 22: Detection of the membrane attack complex (MAC) on the membrane
and membrane vesicles of highly-pathogenic N. Jowlen amoebae incubated with
NHS. Immunofluorescence microscopy of N. Jowlen amoebae incubated with NHS
diluted 1:4 for 15 min (A) ; or 60 min (B) and stained with polyclonal rabbit
antiserum to human MAC proteins (anti-MAC) followed by FITC-Iabeled goat
anti-rabbit IgG antiserum. N. Jowlen amoebae incubated with NHS diluted 1 : 1 6
(C) o r 1: 8 (E) for 30 min and stained with polyclonal anti-MAC antiserum and
FITC goat anti-rabbit IgG and visualized by immunofluorescence microscopy and
N omarski optics microscopy (D & F).
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Figure 23 : Binding of 125I_C9 labeled normal human serum to N. towleri and
release in the form of membrane vesicles. N. towleri LEEm C1 amoebae ( 1 x 1 06 )
were incubated with C9-deficient NHS reconstituted with E25I-C9 for 15- 120 min.
Spontaneous binding was determined by incubating amoebae in heat-inactivated
°
NHS (iNHS) (50 C for 20 min) reconstituted with 1 25I_C9. Following incubation,
the mixture was centrifuged at 1000 x g for 10 sec to pellet intact amoebae (pellet
1). The supernatant was removed and centrifuged at 6000 x g for 20 min to pellet
released membrane vesicles (pellet 2). The counts per minute (cpm) in each
pellet and the percent C9 bound were determined. Error bars denote mean ±
S.D. (n = 3) from a representative experiment. The asterisk denotes statistically
significant difference in percent C9 bound at 15 min as compared to 120 min (p
< 0.0 1).
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increase in the membrane-bound cpm detected in pellet 2 (vesicles).
To visually confirm the contents of the two pellets obtained by differential
centrifugation (pellet 1 and pellet 2), pellets were fixed with glutaraldehyde and
mounted on glass slides for Nomarski optics microscopy. Intact amoebae can
easily be distinguished from membrane vesicles on the basis of size. Differential
centrifugation allowed for the separation of these two populations (Figure 24 A).
Visualization of pellet 1 by Nomarski optics confirmed the presence of
predominately intact amoebae (Figure 24 B).

Pellet 2 contained "released"

membrane vesicles (Figure 24 C). Figure 24 D illustrates the cell-free supernatant
fluid remaining following this procedure. In order to determine the fate of each
of the pellets when incubation was continued in NHS, pellets were generated and
the samples were viewed in the presence of NHS, in the absence of glutaraldehyde
fixation. Intact amoebae were detectable in pellet 1 following prolonged exposure
to NHS, 2-4 h post-incubation (data not shown). However, prolonged exposure
of pellet 2 (membrane vesicles) to NHS for 2-4 h resulted in complete degradation
of the membrane vesicles with cellular debris remaining as evidence of lysed
vesicles (data not shown).

To determine whether membrane blebbing is required for resistance of
pathogenic amoebae to complement lysis, we employed drugs to specifically inhibit
membrane blebbing.

Treatment of pathogenic amoebae with 20J,£g/ml

cytochalasin D or cytochalasin B for 2 h followed by incubation in NHS resulted
in a significant increase in the susceptibility of the amoebae to complement
mediated lysis as measured using the amoebicidal assay (Figure 25). Removal of
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Figure 24 : Nomarski optics microscopy of serum-treated N. Jowleri amoebae and
released membrane vesicles separated by differential centrifugation. N. Jowleri
LEEmpC1 amoebae were incubated with NHS for 15- 120 min. Following
incubation, the mixture was centrifuged at 1000 x g for 10 sec to pellet intact
amoebae (pellet 1). The supernatant was removed and centrifuged at 6000 x g for
20 min to pellet released membrane vesicles (pellet 2). Pellets and supernatant
fluid were fixed with glutaraldehyde at 37·C to give a final concentration of 2.5 %.
Samples were mounted on glass slides and viewed by Nomarski optics microscopy.
(A) Amoebae and vesicles; (B) Pellet 1 containing intact amoebae following
treatment with NHS; (C) Pellet 2 containing released membrane vesicles from
complement-resistant amoebae; (D) cell-free supernatant fluid.
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the drug prior to complement addition resulted in recovery of the amoebae
fromdrug treatment with a concomitant return of the ability to resist complement
lysis. In contrast, treatment of nonpathogenic, complement-sensitive amoebae with
the same concentrations of cytochalasin D or cytochalasin B did not alter
susceptibility of the amoebae to complement lysis.
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Figure 25 : Effect of cytochalasin D or cytochalasin B treatment on susceptibility
of Naeglena amoebae to complement-mediated lysis. N. Jowlen LEEmpC 1 (highly
pathogenic, complement-resistant) and N. gruben EGB (nonpathogenic,
complement-sensitive) amoebae were treated with cytochalasin D (20l-'g/ml) or
cytochalasin B for 2 h at 37 ° C followed by incubation in NHS ± cytochalasin D
or cytochalasin B. Each value represents the percent specific release of radiolabel
(% lysis). Error bars denote mean ± standard error of the mean from a
representative experiment. Similar data were obtained each time the experiment
was repeated. The asterisk denotes stastically significant differences (p < 0.001
for cytochalasin D; p < 0.01 for cytochalasin B).
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Discussion

Naegleria Jowleri amoebae are complement-resistant and highly-virulent in

mice [ 125]. The ability of growth medium to modulate the virulence of pathogenic
N.

Jowleri and susceptibility to complement-mediated lysis provides a mechanism

to correlate virulence and resistance to complement lysis.

These studies

demonstrate that axenic maintenance of highly-pathogenic, mouse-passaged

N.

Jowleri in Nelson medium, a medium which supports the growth of N. Jowleri,

results in a rapid decline in virulence and a concomitant loss of the ability to resist
complement lysis. Maintenance of highly-pathogenic, mouse-passaged amoebae
in Cline medium, which contains supplemental bovine hemin and calf serum
maintains virulence for a longer period of time when grown axenically and
maintains resistance to complement-mediated lysis. These results confirm those
of Wong et al. [ 129] who demonstrated that mice inoculated with amoebae
maintained in Nelson medium showed a decrease in mortality and an increase in
the average time to death. We have determined that at least one ingredient of
Cline medium, bovine hemin, plays a role in modulating the susceptibility of
pathogenic

N.

Jowleri amoebae to complement-mediated lysis.

Iron or iron

containing compounds are important nutrients for N. Jowleri in vivo and in vitro.
1 10

111

Newsome and Wilhelm [82] have suggested that exogenous iron may serve as a
means for controlling the proliferation of pathogenic Naegleria amoebae.

In

addition, the role of hemin in H4 [3] medium was evaluated and shown to be
capable of replacing the need for supplemental serum for growth of Naegleria
amoebae [4].

The role of hemin or iron-containing compounds in virulence

remains to be determined.
The increased resistance of highly-pathogenic amoebae grown in Cline
medium is not due to a difference in activation of the complement cascade since
amoebae grown in either Nelson or Cline medium activate the complement
pathway equally well as determined by the AP-CHso units depleted from serum by
the amoebae grown in either medium. Instead, differences in the susceptibility of
N. Jowleri amoebae to complement lysis following axenic growth in different media

may be due to media-induced differential gene expression or protein synthesis.
Specific ingredients in Cline medium, such as hemin, may allow for the synthesis
of proteins required for resistance to complement or may regulate gene expression
required for complement resistance. To analyze whether amoebae maintained in
different growth media express different proteins, protein profiles of

N.

Jowleri

were examined by SDS PAGE and western immunoblot analysis. In these studies,
growth medium was shown to have a major influence on the p rotein species
synthesized by N. Jowleri amoebae. Protein profiles of highly-pathogenic N. Jowleri
amoebae are more similar to weakly-pathogenic amoebae when both amoebae are
grown in the same medium. However, protein differences observed may not
reflect a change from a weakly-pathogenic to a highly-pathogenic state. Hu et al.
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[40] studied protein synthesis patterns of highly-pathogenic and wealdy-pathognic
N. fowleri amoebae by two-dimensional gel electrophoresis. Changes in proteins
synthesized by axenically cultured or mouse-passaged N. fowleri amoebae were
attributed to whether amoebae were fed bacterial cells, mammalian cells, or grown
in axenic medium. Specific proteins associated with virulence and resistance of
N. fowleri amoebae to complement have not been identified. Surface proteins
which confer resistance to complement lysis have been proposed as possible
virulence markers for highly-pathogenic N. fowleri LEEmpC1 amoebae [6 1, 1 19,
126]. The inability of cycloheximide-treated N. fowleri grown in Nelson medium
to become resistant to complement lysis when switched to growth in Cline medium
corroborates the hypothesis that specific proteins are involved in the mechanism
by which N. fowleri amoebae resist complement-mediated damage. These data
indicate that the synthesis of specific proteins involved in protecting N. fowleri
from complement-mediated damage may be regulated by specific constituents of
growth media.
Proteins induced during growth in different media can be detected with
metabolic-labeling using 35 S-methionine following a shift of the amoebae from
growth in Nelson medium to growth in Cline medium. This method has allowed
for the identification of a number of polypeptides which are uniquely synthesized
by highly-pathogenic, complement-resistant amoebae when grown in Cline
medium.

Hu et al. [40] have identified a number of low molecular mass

polypeptides whose synthesis was influenced in pathogenic N. fowleri amoebae
following a transformation from a low-virulence to a high-virulence state. The
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transformation from a low-virulence state to a high-virulence state was in response
to growth on lawns of bacteria [40]. However, the specific proteins associated with
virulence remain to be identified.
Proteins from pathogenic and nonpathogenic Naegleria were subjected to
biochemical analyses to identify and characterize specific proteins associated with
virulence and complement-resistance. Previously, Whiteman and Marciano-Cabral
[ 126] demonstrated that enzymatic removal of surface components from highly
pathogenic N. fowleri amoebae increased the susceptibility of complement-resistant
amoebae to complement-mediated lysis. Enzymatic treatment of nonpathogenic
or weakly-pathogenic amoebae had no effect on complement-mediated lysis
indicating that specific surface components of highly-pathogenic amoebae play a
role in regulating complement-mediated lysis [ 126]. To determine whether the
membrane components responsible for regulating complement-mediated lysis are
glycosyl-phosphatidylinositol (GPI)-anchored proteins or glycoproteins in nature,
enzymes with specific cleavage sites were utilized. Both PIPLC, which removes
GPI-anchored proteins, and Endo H, which removes high mannose residues
present on glycoproteins increased the susceptibility of resistant amoebae to
complement-mediated lysis, but did not significantly effect complement-mediated
lysis of weakly-pathogenic or nonpathogenic Naeg/eria amoebae. The increased
susceptibility seen after PIPLC treatment of highly-pathogenic Naeg/eria suggests
that N. fowleri amoebae possess a GPI-anchored protein on their surface
membrane which may play a role in regulating the complement pathway. GPI
anchored proteins which confer resistance to complement lysis include decay
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accelerating factor [ 19, 70], homologous restriction factor IC8-binding protein [33],
and CD59 [ 18, 88]. The slight increase in susceptibility of N. Jowleri amoebae to
complement after PIPLC treatment may be due to the fact that many GPI
anchored proteins are relatively resistant to PIPLC release [22, 57, 58]. Weakly
pathogenic amoebae may have the same proteins but to a lesser extent. Increased
concentrations of PIPLC or prolonged treatment with the enzyme can overcome
resistance of certain proteins to release by PIPLC. In the present study, high
concentrations of PIPLC or increased treatment periods were found to be toxic
to Naegleria amoebae (data not shown).
A number of complement regulatory proteins are membrane-bound
glycoproteins. To analyze the role of carbohydrate moieties present on membrane
glycoproteins, we employed the use of endoglycosidase H, an enzyme which
specifically cleaves N-linked high mannose residues of glycoproteins. Treatment
of highly-pathogenic LEEmpCl amoebae with endoglycosidase H increased the
susceptibility of these amoebae to complement lysis.

Treatment of weakly

pathogenic or nonpathogenic strains of Naegleria did not significantly alter
susceptibility to complement-mediated lysis. These data indicate that the proteins
involved in resistance to complement-mediated lysis are glycoproteins. Removal
of N-linked carbohydrates may affect the ability of amoebae to resist lysis by
either altering the conformation of specific proteins or by removing a functional
portion of the protein which is required for inhibition of complement-mediated
lysis.
Tunicamycin, a naturally occurring antibiotic, specifically blocks the
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formation of N-linked protein-carbohydrate linkages and allows for an analysis of
the functional role for specific carbohydrates of glycoproteins. Heterogeneous
preparations of tunicamycin can significantly inhibit protein synthesis in addition
to inhibiting protein glycosylation at asparagine residues [60]. Tunicamycin
treatment of Naeg/eria amoebae for 18 h at a concentration which inhibits
glycosylation, but not protein synthesis, increased the susceptibility of both highly
pathogenic and weakly-pathogenic amoebae to complement lysis, but had no effect
on nonpathogenic, N. gruberi.

These studies support the hypothesis that

glycoproteins are important in the ability of pathogenic amoebae to resist
complement-mediated damage.

Increased susceptibility to complement lysis

following tunicamycin treatment is reversible since the amoebae completely
recover their ability to resist complement damage after removal of the drug and
subsequent incubation in tunicamycin-free medium. A slight increase in the ability
of drug-treated amoebae to resist complement-mediated damage is detected
following removal of the drug. Analysis of de novo synthesized proteins in the
presence of tunicamycin indicates an accumulation of proteins within the amoebae
following an 18 h treatment with the drug. Carbohydrate residues present on
proteins are known to dictate proper protein folding and configuration which are
necessary signals for secretion [27]. Glycoproteins which lack carbohydrates may
either aggregate in the endoplasmic reticulum with subsequent degradation while
other proteins remain unaffected [34, 90]. Increased resistance to complement
lysis following removal of the drug may suggest that tunicamycin-treatment results
in the accumulation of proteins within the amoebae. Removal of tunicamycin

1 16
allows these proteins to become rapidly processed and shuttled to the surface of
the amoebae resulting in a net increase in the concentration of proteins on the
surface of the amoebae enabling the amoebae to more efficiently resist
complement-mediated damage and lysis.
Enzymatic treatment to remove surface components increased the
susceptibility of highly-pathogenic amoebae to complement, whereas inhibition of
protein glycosylation by tunicamycin increased susceptibility of both highly
pathogenic and weakly-pathogenic strains of N. Jowleri. These results indicate that
glycoproteins present on both strains may play a role in protecting the amoebae
from complement, but resistance may be the result of a quantitative difference in
the glycoproteins expressed on the surface of the different strains. Glycoproteins
important in conferring resistance to complement lysis are absent from
nonpathogenic amoebae.
To compare surface proteins present on complement-resistant amoebae
which may be involved in resistance to lysis, we employed surface iodination in
combination with autoradiography.

Four proteins were identified in highly

pathogenic, complement resistant amoebae by this technique which were either
absent or reduced in quantity in the weakly pathogenic LEE strain.

Lectin

staining of surface proteins determined that these unique proteins were
glycoproteins in nature. The attachment of terminal sugars are a major source of
structural diversity for N-linked glycoproteins. Mannose and fucose are known to
be typical sugar residues associated with glycoproteins [90]. In the present study,
lectins specific for the detection of mannose and fucose were used to differentiate
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the carbohydrate residues associated with these surface proteins. Surface proteins
detected in highly-pathogenic LEEmpC1 amoebae contain the carbohydrate
residues, fucose and mannose. Few similarities in surface proteins were detected
between pathogenic N. [owleri and nonpathogenic N. gruberi amoebae.
The recognition of N. [owleri-specific polypeptides with antiserum to human
CD59 suggests that these cross-reactive proteins may possess similar complement
inhibitory function. Immunofluorescence microscopy using anti-CD59 localized
the cross-reacting protein species to the surface of N. [owleri amoebae which is
consistent with its location on RBCs. The ability of NHS to increase the surface
expression of CD59 cross-reacting N. [owleri-polypeptides suggests that
complement components may stimulate de novo synthesis of CD59. The ability
of complement to enhance CD59 expression has been described [ 1 15].
Nonpathogenic N. gruberi amoebae do not appear to express significant levels of
anti-CD59

cross-reacting polypeptides by western

immunoblot

analysis,

immunoprecipitation, or immunofluorescence. The inability of Northern analysis
to identify RNA species in nonpathogenic amoebae which hybridized to CD59
cDNA further corroborates the hypothesis that nonpathogenic amoebae do not
express a CD59-like protein. It has been reported that cDNA to CD59 hybridizes
to four different species of message due to differences in polyadenylation [ 1 18,

123]. However, the inability of antiserum to CD59 or antiserum to polypeptides
identified as unique to highly-pathogenic N. [owleri (46 kDa) to abrogate
complement resistance could be due to the presence of more than one mechanism
for regulating complement by the amoebae.

1 18
The membrane attack complex of the complement system is comprised of
terminal complement components C5b through C9 which damage cell surface
membranes by the formation of transmembrane channels or pores within the
membrane, ultimately resulting in osmotic lysis of the cell [75, 80]. A number of
microorganisms and eukaryotic cells have developed mechanisms to evade
complement lysis. Regulatory proteins present on the surface of cells interfere by
either preventing activation of the complement pathway or by preventing lysis of
the cell once complement has been activated [46, 75] .
In addition t o the presence o f cell surface proteins which inhibit the
complement pathway, a variety of regulatory mechanisms have been identified
which protect cells from damage by the MAC of complement. The mechanisms
which have been described include the ability of cells to shed the MAC (C5b-C9)
from the cell surface in the form of membrane blebs or vesicles (vesiculation),
endocytosis and degradation of membrane-bound C5b-C9 and the inability of the
MAC to become inserted into the cell membrane lipid bilayer due to steric
hindrance [49, 76, 77] .

Several investigators have shown that binding of

complement proteins, C5b through C9 (MAC), induces the production and release
of membrane vesicles from cells such as erythrocytes, platelets, and neutrophils
and serves as a protective mechanism against complement-mediated d am age [77.

1 12].
Various microscopic techniques were employed to evaluate whether highly
pathogenic, complement-resistant

N.

Jowleri amoebae possess an alternative

mechanism for resisting complement lysis, in addition to complement regulatory
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proteins. Nomarski optics microscopy demonstrated that incubation of bighly
pathogenic, complement-resistant amoebae in NHS resulted in the formation of
membrane blebs or vesicles in response to serum complement.

Membrane

vesicles associated with the entire surface of amoebae treated with NHS were
observed using scanning electron microscopy. A greater number of membrane
vesicles were detected on amoebae treated with a 1:8 dilution of NHS when
compared to amoebae treated with NHS diluted 1 :2. These data indicate that
under conditions of low serum concentrations, complement-resistant Naegleria
remove the MAC from their surface by vesiculation. Similarly, Morgan et al.
( 1986ji) have demonstrated that the human histiocytic cell line, U937, escapes
complement-mediated damage in the presence of low doses of C9, by the physical
removal of C5b-C9 from the cell surface. Resistance of highly-pathogenic N.
Jowleri to complement lysis when incubated in high concentrations of serum (ie.

undiluted) may be due to the presence of complement regulatory proteins which
serve as the predominate mechanism for complement regulation. Alternatively,
membrane vesiculation and complement regulatory proteins may act in concert to
allow highly-pathogenic N. Jowleri to escape complement damage.
Using radioiodinated complement component, C9, the presence of C9
binding to the amoeba surface was confirmed. Thus, the inability to form the
membrane attack complex because of a lack of C9 binding was not a mechanism
for complement resistance.
To monitor the formation of the MAC on highly-pathogenic amoebae, an
indirect immunofluorescence assay of N. Jowleri using anti-MAC antiserum was
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performed. Immunofluorescence microscopy confirmed the presence of C5b
through C9 on the surface of the amoebae with identification of the MAC
associated with membrane blebs. Antiserum to the MAC was used to monitor the
location of C5b-C9 at different time intervals following addition of NHS. The
entire surface of the amoebae stained positive for the presence of the MAC
confirming that complement-resistant amoebae are capable of binding the MAC
and localizing the complexes to specific areas on the plasma membrane. The
presence of membrane blebs indicates that the amoebae are capable of removing
portions of their plasma membrane in response to damage by complement
proteins. In addition, a shift in staining intensity from the plasma membrane to
a concentrated staining of the membrane blebs indicates that the portions of
amoeba membrane removed by vesiculation contain deposited membrane attack
complexes. It has been proposed that specific proteins, in particular, GPI-linked
proteins may play a role in triggering vesiculation of erythrocytes [ 128].
Erythrocytes from patients with paroxysmal nocturnal hemoglobinuria as well as
mutant B-Iymphoblastoid cell lines, both lacking GPI-anchored proteins have an
impaired ability to vesiculate in response to complement [ 128] . Membrane
vesiculation by highly-pathogenic, complement-resistant N. Jowleri, also, may be
triggered by cell surface proteins or by the interaction of the MAC with proteins .
associated with the cell surface of the amoebae.
To quantitate the kinetics of C5b-C9 (MAC) binding to the surface of
complement resistant amoebae,

l

�I-C9

binding was combined with differential

centrifugation in order to determine the amount of radioactivity associated with
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intact amoebae or membrane vesicles. An increase in the amount of 125I_C9
associated with the vesicle fraction was detected with increasing incubation in
dilute NHS. This increase in vesicle-associated radioactivity corresponded to a
decrease in the radioactivity associated with intact amoebae.

In addition to

removing the MAC, the released vesicles may serve as a decoy for the binding of
additional complement components, preventing their binding to the amoebae.
Visualization of the fraction containing membrane vesicles not treated with
glutaraldehyde demonstrated complete destruction of the vesicles after prolonged
incubation in serum complement.
The ability of cytochalasin D or cytochalasin B treatment to block exocytic
events such as vesiculation and to significantly increase the susceptibility of highly
pathogenic N. Jowlen amoebae to complement lysis corroborates the importance
of vesiculation as a mechanism by which the amoebae overcome complement
damage.
From this study, the following mechanism of complement resistance of
highly-pathogenic N. Jowlen can be hypothesized (Figure 26). Incubation of N.
Jowlen amoebae in the presence of low concentrations of serum complement

results in ACP activation, and subsequent deposition of the MAC, C5b through
C9,

on

the cell surface of the amoebae. Foll owing MAC deposition, the amoebae

rapidly localize the complexes in their plasma membrane and begin to form
. membrane blebs containing the deposited complement proteins. The removal of
these complexes occurs when the vesicles are exocytosed from the plasma
membrane, a process termed vesiculation. The final fate of the released vesicles

122

is complete destruction by the remaining complement activity present in serum.
The physical removal of the MAC from the cell surface of highly-pathogenic,
complement-resistant amoebae serves as one a mechanism by which the amoebae
protect themselves from complement-mediated lysis. In the presence of high
concentrations of NHS, complement-resistant N. fowleri are protected from
complement-mediated damage not only by their ability to remove surface
associated MAC, but also by their ability to synthesize specific complement
regulatory proteins such as a CD59-like glycoprotein. The combination of cell
surface regulatory proteins and use of mechanisms such as membrane vesiculation,
highly-pathogenic amoebae can resist lysis in high concentrations of serum
complement.
The fact that pathogenic Naegleria amoebae are capable of membrane
vesiculation and the synthesis of proteins similar in function to CD59 is an
important determinant of virulence for this organism. An understanding of these
as well as other virulence mechanisms of pathogenic N. fowleri amoebae will help
in targeting proper treatment regimens for primary amoebic meningoencephalitis.
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Figure 26: Proposed mechanism of complement resistance by highly-pathogenic
N. Jowleri LEEmpC 1 amoebae.
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